Direct generation of functional dopaminergic neurons from mouse and human fibroblasts.
paper
Cited
Public
Unavailable
- Authors
- Caiazzo, Massimiliano; Dell'Anno, Maria Teresa; Dvoretskova, Elena; Lazarevic, Dejan; Taverna, Stefano; Leo, Damiana; Sotnikova, Tatyana D; Menegon, Andrea; Roncaglia, Paola; Colciago, Giorgia; Russo, Giovanni; Carninci, Piero; Pezzoli, Gianni; Gainetdinov, Raul R; Gustincich, Stefano; Dityatev, Alexander; Broccoli, Vania
- Year
- 2011
- Journal
- Nature
- PMID
- 21725324
- DOI
- 10.1038/nature10284
Transplantation of dopaminergic neurons can potentially improve the clinical outcome of Parkinson's disease, a neurological disorder resulting from degeneration of mesencephalic dopaminergic neurons. In particular, transplantation of embryonic-stem-cell-derived dopaminergic neurons has been shown to be efficient in restoring motor symptoms in conditions of dopamine deficiency. However, the use of pluripotent-derived cells might lead to the development of tumours if not properly controlled. Here we identified a minimal set of three transcription factors--Mash1 (also known as Ascl1), Nurr1 (also known as Nr4a2) and Lmx1a--that are able to generate directly functional dopaminergic neurons from mouse and human fibroblasts without reverting to a progenitor cell stage. Induced dopaminergic (iDA) cells release dopamine and show spontaneous electrical activity organized in regular spikes consistent with the pacemaker activity featured by brain dopaminergic neurons. The three factors were able to elicit dopaminergic neuronal conversion in prenatal and adult fibroblasts from healthy donors and Parkinson's disease patients. Direct generation of iDA cells from somatic cells might have significant implications for understanding critical processes for neuronal development, in vitro disease modelling and cell replacement therapies.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Differentiation of human iPSCs into dopaminergic neurons: comparative analysis of 2D and 3D protocols for disease modeling and pharmacology. | Marcotto GS et al. | β | 2026 | β |
| Direct neuronal reprogramming: emerging therapeutic strategies for neurodegenerative disorders. | Tyagi A et al. | β | 2026 | β |
| Mettl3 promotes reprogramming and axonogenesis of induced retinal ganglion cells. | Zhang K et al. | β | 2026 | β |
| Nasal Mucosa-Derived Ectodermal Mesenchymal Stem Cells for Parkinson's Therapy: From Developmental Insights to Application. | Wang Z et al. | β | 2026 | β |
| Neuronal Transdifferentiation in Humans: Protocols for Monocytes Conversion into Neuronal-Like Cells with Small Molecules. | Jankowska K et al. | β | 2026 | β |
| Properties and Application of Pseudotyped Lentiviral Vectors. | Matsushita N et al. | β | 2026 | β |
| Simulation-guided chemical direct reprogramming informed by temporal cellular conversion processes at the single-cell level. | Ito R et al. | β | 2026 | β |
| Adult hippocampal neurogenesis: New avenues for treatment of brain disorders. | Chen L et al. | β | 2025 | β |
| Advances in Stem Cell Therapy for Huntington's Disease: A Comprehensive Literature Review. | Shah S et al. | β | 2025 | β |
| Anchored screening identifies transcription factor blueprints underlying dendritic cell diversity and subset-specific anti-tumor immunity. | Henriques-Oliveira L et al. | β | 2025 | β |
| Cell-based regenerative and rejuvenation strategies for treating neurodegenerative diseases. | Deng S et al. | β | 2025 | β |
| Cell fate acquisition and reprogramming by the proneural transcription factor ASCL1. | Lundie-Brown J et al. | β | 2025 | β |
| Cell reprogramming: methods, mechanisms and applications. | Zhu F et al. | β | 2025 | β |
| Cortisol regulates neonatal lung development via Smoothened. | Lu S et al. | β | 2025 | β |
| Direct reprogramming of fibroblasts into spiral ganglion neurons by defined transcription factors. | Huang Y et al. | β | 2025 | β |
| Excessive DNA Double-Strand Breaks-Associated 3D Genome Reorganization Contributes to Neural Tube Defects with Folate Deficiency. | Zhang T et al. | β | 2025 | β |
| Investigating the ageing-Parkinson's disease nexus: standardisation of in vitro models and techniques by the PD-AGE network. | Bury AG et al. | β | 2025 | β |
| Molecular Determinants of A9 Dopaminergic Neurons. | Mishra AK et al. | β | 2025 | β |
| Reprogramming of skin fibroblasts by 3D spheroid culture promotes peripheral nerve regeneration via the ID3/semaphorin7a pathway. | Tan X et al. | β | 2025 | β |
| Somatic cell reprogramming for Parkinson's disease treatment. | Li X et al. | β | 2025 | β |
| Three-dimensional cell-cell interactions promote direct reprogramming of patient fibroblasts into functional and transplantable neurons. | Kajtez J et al. | β | 2025 | β |
| Age- and disease-related autophagy impairment in Huntington disease: New insights from direct neuronal reprogramming. | Luo C et al. | β | 2024 | β |
| Cell reprogramming therapy for Parkinson's disease. | Dong W et al. | β | 2024 | β |
| Chemical transdifferentiation of somatic cells to neural cells: a systematic review. | Visintin PV et al. | β | 2024 | β |
| Controlling the Expression Level of the Neuronal Reprogramming Factors for a Successful Reprogramming Outcome. | Mseis-Jackson N et al. | β | 2024 | β |
| DIRECTEUR: transcriptome-based prediction of small molecules that replace transcription factors for direct cell conversion. | Hamano M et al. | β | 2024 | β |
| Forced LMX1A expression induces dorsal neural fates and disrupts patterning of human embryonic stem cells into ventral midbrain dopaminergic neurons. | Rifes P et al. | β | 2024 | β |
| Generation of functional neurons from adult human mucosal olfactory ensheathing glia by direct lineage conversion. | Portela-Lomba M et al. | β | 2024 | β |
| Generation of human excitatory forebrain neurons by cooperative binding of proneural NGN2 and homeobox factor EMX1. | Ang CE et al. | β | 2024 | β |
| Glial-restricted progenitor cells: a cure for diseased brain? | Rogujski P et al. | β | 2024 | β |
| Introduction to stem cell biology and its role in treating neurologic disorders. | Parmar M et al. | β | 2024 | β |
| In vitro human cell culture models in a bench-to-bedside approach to epilepsy. | DanaΔΓkovΓ‘ Ε et al. | β | 2024 | β |
| Lineage Reprogramming: Genetic, Chemical, and Physical Cues for Cell Fate Conversion with a Focus on Neuronal Direct Reprogramming and Pluripotency Reprogramming. | Umeyama T et al. | β | 2024 | β |
| Neurog1 and Olig2 integrate patterning and neurogenesis signals in development of zebrafish dopaminergic and glutamatergic dual transmitter neurons. | AltbΓΌrger C et al. | β | 2024 | β |
| Neuronal reprogramming of mouse and human fibroblasts using transcription factors involved in suprachiasmatic nucleus development. | Hirayama M et al. | β | 2024 | β |
| Non-coding RNAs as therapeutic targets in Parkinson's Disease: A focus on dopamine. | Alharbi KS | β | 2024 | β |
| Oncogenic Role of SATB2 In Vitro: Regulator of Pluripotency, Self-Renewal, and Epithelial-Mesenchymal Transition in Prostate Cancer. | Yu W et al. | β | 2024 | β |
| Patient-derived neuron model: Capturing age-dependent adult-onset degenerative pathology in Huntington's disease. | Oh YM et al. | β | 2024 | β |
| Probing the molecular and cellular pathological mechanisms of schizophrenia using human induced pluripotent stem cell models. | Sebastian R et al. | β | 2024 | β |
| Progress in direct reprogramming of dopaminergic cell replacement therapy. | Zheng YY et al. | β | 2024 | β |
| Rapid induction of dopaminergic neuron-like cells from human fibroblasts by autophagy activation with only 2-small molecules. | Sorraksa N et al. | β | 2024 | β |
| Screens in aging-relevant human ALS-motor neurons identify MAP4Ks as therapeutic targets for the disease. | Liu ML et al. | β | 2024 | β |
| Small molecules reprogram reactive astrocytes into neuronal cells in the injured adult spinal cord. | Tan Z et al. | β | 2024 | β |
| Structural insights into the recognition of the A/T-rich motif in target gene promoters by the LMX1a homeobox domain. | Lin L et al. | β | 2024 | β |
| The Neuroanatomy of Induced Pluripotent Stem Cells: In Vitro Models of Subcortical Nuclei in Neurodegenerative Disorders. | Galgani A et al. | β | 2024 | β |
| The proneural factors Ascl1a and Ascl1b contribute to the terminal differentiation of dopaminergic GABAergic dual transmitter neurons in zebrafish. | AltbΓΌrger C et al. | β | 2024 | β |
| Transcription Factor-Mediated Generation of Dopaminergic Neurons from Human iPSCs-A Comparison of Methods. | McDonald KO et al. | β | 2024 | β |
| Unravelling the Parkinson's puzzle, from medications and surgery to stem cells and genes: a comprehensive review of current and future management strategies. | Chandrababu K et al. | β | 2024 | β |
| Astrocyte-to-neuron reprogramming and crosstalk in the treatment of Parkinson's disease. | Wang Y et al. | β | 2023 | β |
| Efficient Generation of Dopaminergic Neurons from Mouse Ventral Midbrain Astrocytes. | Han JY et al. | β | 2023 | β |
| Engineering Female Germline Stem Cells with Exocytotic Polymer Dots. | Luo Y et al. | β | 2023 | β |
| From 2D to 3D: Development of Monolayer Dopaminergic Neuronal and Midbrain Organoid Cultures for Parkinson's Disease Modeling and Regenerative Therapy. | Yeap YJ et al. | β | 2023 | β |
| Generation of self-organized autonomic ganglion organoids from fibroblasts. | Liu S et al. | β | 2023 | β |
| Gene Therapy Using Efficient Direct Lineage Reprogramming Technology for Neurological Diseases. | Chang Y et al. | β | 2023 | β |
| Human pluripotent stem cell (hPSC) and organoid models of autism: opportunities and limitations. | Kilpatrick S et al. | β | 2023 | β |
| Induction of dopaminergic neurons for neuronal subtype-specific modeling of psychiatric disease risk. | Powell SK et al. | β | 2023 | β |
| miR-218 Promotes Dopaminergic Differentiation and Controls Neuron Excitability and Neurotransmitter Release through the Regulation of a Synaptic-Related Genes Network. | Pulcrano S et al. | β | 2023 | β |
| Molecular pathways of major depressive disorder converge on the synapse. | Fries GR et al. | β | 2023 | β |
| Moving CNS axon growth and regeneration research into human model systems. | Lear BP et al. | β | 2023 | β |
| Neural progenitor cells derived from fibroblasts induced by small molecule compounds under hypoxia for treatment of Parkinson's disease in rats. | Guo Y et al. | β | 2023 | β |
| Nicotine-Mediated Recruitment of GABAergic Neurons to a Dopaminergic Phenotype Attenuates Motor Deficits in an Alpha-Synuclein Parkinson's Model. | Lai JI et al. | β | 2023 | β |
| PARIS undergoes liquid-liquid phase separation and poly(ADP-ribose)-mediated solidification. | Kang H et al. | β | 2023 | β |
| Reactive astrocytes targeting with oral vitamin A: Efficient neuronal regeneration for Parkinson's disease treatment and reversal of associated liver fibrosis. | El-Mezayen NS et al. | β | 2023 | β |
| Regulation of Cell Plasticity by Bromodomain and Extraterminal Domain (BET) Proteins: A New Perspective in Glioblastoma Therapy. | Gargano D et al. | β | 2023 | β |
| Strategies and mechanisms of neuronal reprogramming. | Wan Y et al. | β | 2023 | β |
| The efficient induction of human retinal ganglion-like cells provides a platform for studying optic neuropathies. | Liou RH et al. | β | 2023 | β |
| The Influence of Prenatal Exposure to Methamphetamine on the Development of Dopaminergic Neurons in the Ventral Midbrain. | Alsanie WF et al. | β | 2023 | β |
| The role of pioneer transcription factors in the induction of direct cellular reprogramming. | Horisawa K et al. | β | 2023 | β |
| The role of purinergic receptors in neural repair and regeneration after spinal cord injury. | Cheng RD et al. | β | 2023 | β |
| Transition from Animal-Based to Human Induced Pluripotent Stem Cells (iPSCs)-Based Models of Neurodevelopmental Disorders: Opportunities and Challenges. | Guerreiro S et al. | β | 2023 | β |
| Use of <i>in vitro</i> derived human neuronal models to study host-parasite interactions of <i>Toxoplasma gondii</i> in neurons and neuropathogenesis of chronic toxoplasmosis. | Halonen SK | β | 2023 | β |
| Age-related pathological impairments in directly reprogrammed dopaminergic neurons derived from patients with idiopathic Parkinson's disease. | Drouin-Ouellet J et al. | β | 2022 | β |
| Application and prospects of high-throughput screening for <i>in vitro</i> neurogenesis. | Zhang SY et al. | β | 2022 | β |
| Cell models for Down syndrome-Alzheimer's disease research. | Wu Y et al. | β | 2022 | β |
| Cell Reprogramming for Regeneration and Repair of the Nervous System. | Clark IH et al. | β | 2022 | β |
| Changing Fate: Reprogramming Cells via Engineered Nanoscale Delivery Materials. | Soltani Dehnavi S et al. | β | 2022 | β |
| Chiral-at-Cage Carboranes for Circularly Polarized Luminescence and Aggregation-Induced Electrochemiluminescence. | Tong J et al. | β | 2022 | β |
| Circuit formation in the adult brain. | Seng C et al. | β | 2022 | β |
| Coordinated control of neuronal differentiation and wiring by sustained transcription factors. | Γzel MN et al. | β | 2022 | β |
| Dead Cas(t) light on new life: CRISPRa-mediated reprogramming of somatic cells into neurons. | Zhou M et al. | β | 2022 | β |
| Derivation of Stem Cell-like Cells From Spherical Culture of Astrocytes for Enhanced Neural Repair After Middle Cerebral Artery Occlusion. | Zhu D et al. | β | 2022 | β |
| Direct Cell Conversion of Somatic Cells into Dopamine Neurons: Achievements and Perspectives. | Aversano S et al. | β | 2022 | β |
| Direct Conversion of Cell Fate and Induced Endothelial Cells. | Han JK et al. | β | 2022 | β |
| Direct neuronal reprogramming: Fast forward from new concepts toward therapeutic approaches. | Bocchi R et al. | β | 2022 | β |
| Disease Modeling of Neurodegenerative Disorders Using Direct Neural Reprogramming. | Legault EM et al. | β | 2022 | β |
| Dynamics and Pathways of Chromosome Structural Organizations during Cell Transdifferentiation. | Chu X et al. | β | 2022 | β |
| Foxa2 and Pet1 Direct and Indirect Synergy Drive Serotonergic Neuronal Differentiation. | Aydin B et al. | β | 2022 | β |
| Genetic loss of function of Ptbp1 does not induce glia-to-neuron conversion in retina. | Hoang T et al. | β | 2022 | β |
| Induced pluripotent stem cell-derived and directly reprogrammed neurons to study neurodegenerative diseases: The impact of aging signatures. | Aversano S et al. | β | 2022 | β |
| Lmx1a-Dependent Activation of miR-204/211 Controls the Timing of Nurr1-Mediated Dopaminergic Differentiation. | Pulcrano S et al. | β | 2022 | β |
| MicroRNA Roles in Cell Reprogramming Mechanisms. | Pascale E et al. | β | 2022 | β |
| Parkinson's disease motor symptoms rescue by CRISPRa-reprogramming astrocytes into GABAergic neurons. | Giehrl-Schwab J et al. | β | 2022 | β |
| Parkinson's Disease: Overview of Transcription Factor Regulation, Genetics, and Cellular and Animal Models. | Xia N et al. | β | 2022 | β |
| Pluripotent stem cell strategies for rebuilding the human brain. | Limone F et al. | β | 2022 | β |
| Prenatal Exposure to Gabapentin Alters the Development of Ventral Midbrain Dopaminergic Neurons. | Alsanie WF et al. | β | 2022 | β |
| Probing cell identity hierarchies by fate titration and collision during direct reprogramming. | Hersbach BA et al. | β | 2022 | β |
| Progression in translational research on spinal cord injury based on microenvironment imbalance. | Fan B et al. | β | 2022 | β |
| Rapid Conversion of Human Induced Pluripotent Stem Cells into Dopaminergic Neurons by Inducible Expression of Two Transcription Factors. | Nishimura K et al. | β | 2022 | β |
| Reprogramming of Rat Fibroblasts into Induced Neurons by Small-Molecule Compounds In Vitro and In Vivo. | Wang X et al. | β | 2022 | β |
| Restoration of spinal cord injury: From endogenous repairing process to cellular therapy. | Wu Y et al. | β | 2022 | β |
| Revealing the Impact of Mitochondrial Fitness During Early Neural Development Using Human Brain Organoids. | Romero-Morales AI et al. | β | 2022 | β |
| Roles of Transcription Factors in the Development and Reprogramming of the Dopaminergic Neurons. | Tian L et al. | β | 2022 | β |
| Somatic Lineage Reprogramming. | Shelby H et al. | β | 2022 | β |
| The bHLH Transcription Factors in Neural Development and Therapeutic Applications for Neurodegenerative Diseases. | Lee DG et al. | β | 2022 | β |
| The Effects of Prenatal Exposure to Pregabalin on the Development of Ventral Midbrain Dopaminergic Neurons. | Alsanie WF et al. | β | 2022 | β |
| The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders. | Olesen MA et al. | β | 2022 | β |
| [VCR, a Small Molecule Compound, Induces Reprogramming of Rat Fibroblasts into Neural Progenitor Cells under Hypoxic Condition]. | Wang YY et al. | β | 2022 | β |
| Vesicular Glutamate Release from Feeder-FreehiPSC-Derived Neurons. | Baldassari S et al. | β | 2022 | β |
| Altered heparan sulfate metabolism during development triggers dopamine-dependent autistic-behaviours in models of lysosomal storage disorders. | De Risi M et al. | β | 2021 | β |
| Brain Repair by Cell Replacement via In Situ Neuronal Reprogramming. | Qian H et al. | β | 2021 | β |
| Cell Transdifferentiation and Reprogramming in Disease Modeling: Insights into the Neuronal and Cardiac Disease Models and Current Translational Strategies. | Kalra RS et al. | β | 2021 | β |
| Conversion of mouse embryonic fibroblasts into neural crest cells and functional corneal endothelia by defined small molecules. | Pan SH et al. | β | 2021 | β |
| Current and future applications of induced pluripotent stem cell-based models to study pathological proteins in neurodegenerative disorders. | de Rus Jacquet A et al. | β | 2021 | β |
| Current Approaches and Molecular Mechanisms for Directly Reprogramming Fibroblasts Into Neurons and Dopamine Neurons. | Han F et al. | β | 2021 | β |
| Decoding Neuronal Diversification by Multiplexed Single-cell RNA-Seq. | LuginbΓΌhl J et al. | β | 2021 | β |
| Delivery of transcription factors as modulators of cell differentiation. | Rilo-Alvarez H et al. | β | 2021 | β |
| Direct Cell Reprogramming of Mouse Fibroblasts into Functional Astrocytes Using Lentiviral Overexpression of the Transcription Factors NFIA, NFIB, and SOX9. | Qiu B et al. | β | 2021 | β |
| Direct Neuronal Reprogramming: Bridging the Gap Between Basic Science and Clinical Application. | Vasan L et al. | β | 2021 | β |
| Direct Reprogramming of Fibroblasts to Astrocytes Using Small Molecules. | Tian E et al. | β | 2021 | β |
| Efficient conversion of human induced pluripotent stem cells into microglia by defined transcription factors. | Chen SW et al. | β | 2021 | β |
| Efficient generation of dopaminergic induced neuronal cells with midbrain characteristics. | Ng YH et al. | β | 2021 | β |
| Generation of Induced Dopaminergic Neurons from Human Fetal Fibroblasts. | Legault EM et al. | β | 2021 | β |
| Human iPSC-Derived Neurons as A Platform for Deciphering the Mechanisms behind Brain Aging. | Chao CC et al. | β | 2021 | β |
| Human Keratinocytes Adopt Neuronal Fates After <i>In Utero</i> Transplantation in the Developing Rat Brain. | Tenorio-Mina A et al. | β | 2021 | β |
| Identification of ASCL1 as a determinant for human iPSC-derived dopaminergic neurons. | Earley AM et al. | β | 2021 | β |
| <i>In vivo</i> Direct Conversion of Astrocytes to Neurons Maybe a Potential Alternative Strategy for Neurodegenerative Diseases. | Wang Y et al. | β | 2021 | β |
| Improved Method for Efficient Generation of Functional Neurons from Murine Neural Progenitor Cells. | Soni A et al. | β | 2021 | β |
| Kill Three Birds with One Stone: Poly(3,4-ethylenedioxythiophene)-Hosted Ag Nanoclusters with Boosted Cathodic Electrochemiluminescence for Biosensing Application. | Nie Y et al. | β | 2021 | β |
| Lineage tracing of direct astrocyte-to-neuron conversion in the mouse cortex. | Xiang Z et al. | β | 2021 | β |
| Live Imaging of Primary Neurons in Long-Term Cryopreserved Human Nerve Tissue. | Fortea M et al. | β | 2021 | β |
| Making Sense of Patient-Derived iPSCs, Transdifferentiated Neurons, Olfactory Neuronal Cells, and Cerebral Organoids as Models for Psychiatric Disorders. | Unterholzner J et al. | β | 2021 | β |
| Molecular Mechanisms Underlying Ascl1-Mediated Astrocyte-to-Neuron Conversion. | Rao Z et al. | β | 2021 | β |
| New Insights Into the Intricacies of Proneural Gene Regulation in the Embryonic and Adult Cerebral Cortex. | Oproescu AM et al. | β | 2021 | β |
| Potential protective role of astrocytes in the pathogenesis of astrocyte-mediated synaptic plasticity of Parkinson's disease. | Zhang Y et al. | β | 2021 | β |
| Ptbp1 deletion does not induce glia-to-neuron conversion in adult mouse retina and brain | Hoang T et al. | β | 2021 | β |
| Publicly Available hiPSC Lines with Extreme Polygenic Risk Scores for Modeling Schizophrenia. | Dobrindt K et al. | β | 2021 | β |
| Reprogramming astrocytes to motor neurons by activation of endogenous Ngn2 and Isl1. | Zhou M et al. | β | 2021 | β |
| Reprogramming Human Adult Fibroblasts into GABAergic Interneurons. | Bruzelius A et al. | β | 2021 | β |
| Targeting Ξ±-Synuclein in Parkinson's Disease by Induced Pluripotent Stem Cell Models. | Spathopoulou A et al. | β | 2021 | β |
| The application of in vitro-derived human neurons in neurodegenerative disease modeling. | D'Souza GX et al. | β | 2021 | β |
| The Different Molecular Code in Generation of Dopaminergic Neurons from Astrocytes and Mesenchymal Stem Cells. | Wang N et al. | β | 2021 | β |
| A decade of questions about the fluidity of cell identity. | Masserdotti G et al. | β | 2020 | β |
| Advances in mt-tRNA Mutation-Caused Mitochondrial Disease Modeling: Patients' Brain in a Dish. | Povea-Cabello S et al. | β | 2020 | β |
| Bioprinting Neural Systems to Model Central Nervous System Diseases. | Qiu B et al. | β | 2020 | β |
| Computational advances of tumor marker selection and sample classification in cancer proteomics. | Tang J et al. | β | 2020 | β |
| Development and Differentiation of Midbrain Dopaminergic Neuron: From Bench to Bedside. | Wang M et al. | β | 2020 | β |
| Differentiation of human pluripotent stem cells toward pharyngeal endoderm derivatives: Current status and potential. | Magaletta ME et al. | β | 2020 | β |
| Direct cell-fate conversion of somatic cells: Toward regenerative medicine and industries. | Horisawa K et al. | β | 2020 | β |
| Direct conversion of human fibroblasts into dopaminergic neuron-like cells using small molecules and protein factors. | Qin H et al. | β | 2020 | β |
| Direct Conversion of Human Stem Cell-Derived Glial Progenitor Cells into GABAergic Interneurons. | Giacomoni J et al. | β | 2020 | β |
| Direct Lineage Reprogramming in the CNS. | Bajohr J et al. | β | 2020 | β |
| Direct Reprogramming of Human Fetal- and Stem Cell-Derived Glial Progenitor Cells into Midbrain Dopaminergic Neurons. | Nolbrant S et al. | β | 2020 | β |
| Engineering Biomaterials with Micro/Nanotechnologies for Cell Reprogramming. | Fang J et al. | β | 2020 | β |
| Epigenomic analysis of Parkinson's disease neurons identifies Tet2 loss as neuroprotective. | Marshall LL et al. | β | 2020 | β |
| From in vitro to in vivo reprogramming for neural transdifferentiation: An approach for CNS tissue remodeling using stem cell technology. | Egawa N et al. | β | 2020 | β |
| Full small molecule conversion of human fibroblasts to neuroectodermal cells via a cocktail of Dorsomorphin and Trichostatin A. | Hosseini Farahabadi SS et al. | β | 2020 | β |
| How to reprogram human fibroblasts to neurons. | Xu Z et al. | β | 2020 | β |
| Human Autopsy-Derived Scalp Fibroblast Biobanking for Age-Related Neurodegenerative Disease Research. | Beh ST et al. | β | 2020 | β |
| Human Pluripotent Stem Cell-Derived Neural Cells as a Relevant Platform for Drug Screening in Alzheimer's Disease. | Garcia-Leon JA et al. | β | 2020 | β |
| Integrating CRISPR Engineering and hiPSC-Derived 2D Disease Modeling Systems. | Rehbach K et al. | β | 2020 | β |
| Investigation of Schizophrenia with Human Induced Pluripotent Stem Cells. | Powell SK et al. | β | 2020 | β |
| iPSC modeling of rare pediatric disorders. | Freel BA et al. | β | 2020 | β |
| Method to combat Parkinson's disease by astrocyte-to-neuron conversion. | Arenas E | β | 2020 | β |
| Modeling Alzheimer's disease with iPSC-derived brain cells. | Penney J et al. | β | 2020 | β |
| Molecular Regulation in Dopaminergic Neuron Development. Cues to Unveil Molecular Pathogenesis and Pharmacological Targets of Neurodegeneration. | Volpicelli F et al. | β | 2020 | β |
| Neuronal differentiation strategies: insights from single-cell sequencing and machine learning. | Konstantinides N et al. | β | 2020 | β |
| Neuronal Reprogramming for Tissue Repair and Neuroregeneration. | Liou RH et al. | β | 2020 | β |
| Noncoding RNAs and Midbrain DA Neurons: Novel Molecular Mechanisms and Therapeutic Targets in Health and Disease. | Pascale E et al. | β | 2020 | β |
| Novel Glial Cell Functions: Extensive Potency, Stem Cell-Like Properties, and Participation in Regeneration and Transdifferentiation. | Milichko V et al. | β | 2020 | β |
| Nrf2/Wnt resilience orchestrates rejuvenation of glia-neuron dialogue in Parkinson's disease. | Marchetti B | β | 2020 | β |
| On the Right Track to Treat Movement Disorders: Promising Therapeutic Approaches for Parkinson's and Huntington's Disease. | Troncoso-Escudero P et al. | β | 2020 | β |
| Overexpression of the transcription factors OCT4 and KLF4 improves motor function after spinal cord injury. | Huang X et al. | β | 2020 | β |
| Parkin mutation decreases neurite complexity and maturation in neurons derived from human fibroblasts. | Pu J et al. | β | 2020 | β |
| Patient-Derived Midbrain Organoids to Explore the Molecular Basis of Parkinson's Disease. | Galet B et al. | β | 2020 | β |
| Precision Medicine in Rare Diseases. | VillalΓ³n-GarcΓa I et al. | β | 2020 | β |
| Prospects of Directly Reprogrammed Adult Human Neurons for Neurodegenerative Disease Modeling and Drug Discovery: iN vs. iPSCs Models. | Zhang Y et al. | β | 2020 | β |
| Quick Commitment and Efficient Reprogramming Route of Direct Induction of Retinal Ganglion Cell-like Neurons. | Wang J et al. | β | 2020 | β |
| Regeneration Through <i>in vivo</i> Cell Fate Reprogramming for Neural Repair. | Tai W et al. | β | 2020 | β |
| Reversing a model of Parkinson's disease with in situ converted nigral neurons. | Qian H et al. | β | 2020 | β |
| Stem Cell Therapy for Parkinson's Disease. | Han F et al. | β | 2020 | β |
| Susceptibility to Cardiac Arrhythmias and Sympathetic Nerve Growth in VEGF-B Overexpressing Myocardium. | LΓ€hteenvuo J et al. | β | 2020 | β |
| The iNs and Outs of Direct Reprogramming to Induced Neurons. | Carter JL et al. | β | 2020 | β |
| The leading edge: Emerging neuroprotective and neuroregenerative cell-based therapies for spinal cord injury. | Ahuja CS et al. | β | 2020 | β |
| Toward Generating Subtype-Specific Mesencephalic Dopaminergic Neurons <i>in vitro</i>. | Cardoso T et al. | β | 2020 | β |
| Transdifferentiation of Mouse Embryonic Fibroblasts into Dopaminergic Neurons Reactivates LINE-1 Repetitive Elements. | Della Valle F et al. | β | 2020 | β |
| What we can learn from iPSC-derived cellular models of Parkinson's disease. | Caiazza MC et al. | β | 2020 | β |
| Acquisition of functional neurons by direct conversion: Switching the developmental clock directly. | Chen S et al. | β | 2019 | β |
| A Revolution in Reprogramming: Small Molecules. | Zhou J et al. | β | 2019 | β |
| Attenuation of PRRX2 and HEY2 enables efficient conversion of adult human skin fibroblasts to neurons. | Li H et al. | β | 2019 | β |
| bHLH transcription factors in neural development, disease, and reprogramming. | Dennis DJ et al. | β | 2019 | β |
| Brain Organoids: A New, Transformative Investigational Tool for Neuroscience Research. | Vaez Ghaemi R et al. | β | 2019 | β |
| Brain Organoids as Tools for Modeling Human Neurodevelopmental Disorders. | Adams JW et al. | β | 2019 | β |
| Cell-based therapy for Parkinson's disease: A journey through decades toward the light side of the Force. | Parmar M et al. | β | 2019 | β |
| Cell Reprogramming: The Many Roads to Success. | Aydin B et al. | β | 2019 | β |
| Chemical modulation of transcriptionally enriched signaling pathways to optimize the conversion of fibroblasts into neurons. | Herdy J et al. | β | 2019 | β |
| Chemotherapy-Induced Neuropathy and Drug Discovery Platform Using Human Sensory Neurons Converted Directly from Adult Peripheral Blood. | Vojnits K et al. | β | 2019 | β |
| Conversion of Astrocytes and Fibroblasts into Functional Noradrenergic Neurons. | Li S et al. | β | 2019 | β |
| Conversion of human and mouse fibroblasts into lung-like epithelial cells. | Wong AP et al. | β | 2019 | β |
| CRISPR-activation-based screen reveals neuronal fate promotion by polycomb repressive complex 2 during direct reprogramming. | Wolfram T et al. | β | 2019 | β |
| Dedifferentiation, transdifferentiation and cell fusion: inΒ vivo reprogramming strategies for regenerative medicine. | Pesaresi M et al. | β | 2019 | β |
| Direct neuronal reprogramming of olfactory ensheathing cells for CNS repair. | Sun X et al. | β | 2019 | β |
| Direct Neuronal Reprogramming Reveals Unknown Functions for Known Transcription Factors. | Colasante G et al. | β | 2019 | β |
| Direct reprogramming into interneurons: potential for brain repair. | Pereira M et al. | β | 2019 | β |
| Direct Reprogramming to Human Induced Neuronal Progenitors from Fibroblasts of Familial and Sporadic Parkinson's Disease Patients. | Lee M et al. | β | 2019 | β |
| Dual modulation of neuron-specific microRNAs and the REST complex promotes functional maturation of human adult induced neurons. | Birtele M et al. | β | 2019 | β |
| Evolving principles underlying neural lineage conversion and their relevance for biomedical translation. | Flitsch LJ et al. | β | 2019 | β |
| Forskolin and IBMX Induce Neural Transdifferentiation of MSCs Through Downregulation of the NRSF. | Thompson R et al. | β | 2019 | β |
| Induced pluripotent stem cell-based modeling of mutant LRRK2-associated Parkinson's disease. | Weykopf B et al. | β | 2019 | β |
| Lethal Factor Domain-Mediated Delivery of Nurr1 Transcription Factor Enhances Tyrosine Hydroxylase Activity and Protects from Neurotoxin-Induced Degeneration of Dopaminergic Cells. | Paliga D et al. | β | 2019 | β |
| Making NSC and Neurons from Patient-Derived Tissue Samples. | Mukherjee O et al. | β | 2019 | β |
| Metastable Reprogramming State of Single Transcription Factor-Derived Induced Hepatocyte-Like Cells. | Hwang SI et al. | β | 2019 | β |
| Next-generation disease modeling with direct conversion: a new path to old neurons. | Traxler L et al. | β | 2019 | β |
| Non-engineered and Engineered Adult Neurogenesis in Mammalian Brains. | Lei W et al. | β | 2019 | β |
| Novel Tools towards Magnetic Guidance of Neurite Growth: (I) Guidance of Magnetic Nanoparticles into Neurite Extensions of Induced Human Neurons and In Vitro Functionalization with RAS Regulating Proteins. | SchΓΆneborn H et al. | β | 2019 | β |
| ONECUT transcription factors induce neuronal characteristics and remodel chromatin accessibility. | van der Raadt J et al. | β | 2019 | β |
| Pharmacological Transdifferentiation of Human Nasal Olfactory Stem Cells into Dopaminergic Neurons. | Chabrat A et al. | β | 2019 | β |
| Plasmid-based generation of neural cells from human fibroblasts using non-integrating episomal vectors. | Dai SB et al. | β | 2019 | β |
| Rapid and Efficient Conversion of Human Fibroblasts into Functional Neurons by Small Molecules. | Yang Y et al. | β | 2019 | β |
| Single-cell multimodal transcriptomics to study neuronal diversity in human stem cell-derived brain tissue and organoid models. | van den Hurk M et al. | β | 2019 | β |
| Small molecules enhance neurogenic differentiation of dental-derived adult stem cells. | Heng BC et al. | β | 2019 | β |
| Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models. | Logan S et al. | β | 2019 | β |
| Take the shortcut - direct conversion of somatic cells into induced neural stem cells and their biomedical applications. | Erharter A et al. | β | 2019 | β |
| The Chromatin Environment Around Interneuron Genes in Oligodendrocyte Precursor Cells and Their Potential for Interneuron Reprograming. | Boshans LL et al. | β | 2019 | β |
| The microRNA-29a Modulates Serotonin 5-HT7 Receptor Expression and Its Effects on Hippocampal Neuronal Morphology. | Volpicelli F et al. | β | 2019 | β |
| Transcription Factor-Directed Re-wiring of Chromatin Architecture for Somatic Cell Nuclear Reprogramming toward trans-Differentiation. | Dall'Agnese A et al. | β | 2019 | β |
| Transcription Factors That Govern Development and Disease: An Achilles Heel in Cancer. | Huilgol D et al. | β | 2019 | β |
| Transcriptome Analysis of Small Molecule-Mediated Astrocyte-to-Neuron Reprogramming. | Ma NX et al. | β | 2019 | β |
| Using transcription factors for direct reprogramming of neurons <i>in vitro</i>. | El Wazan L et al. | β | 2019 | β |
| Aging in a Dish: iPSC-Derived and Directly Induced Neurons for Studying Brain Aging and Age-Related Neurodegenerative Diseases. | Mertens J et al. | β | 2018 | β |
| Cell reprogramming approaches in gene- and cell-based therapies for Parkinson's disease. | Man JHK et al. | β | 2018 | β |
| Chemical compound-based direct reprogramming for future clinical applications. | Takeda Y et al. | β | 2018 | β |
| Clinical Cell Therapy Guidelines for Neurorestoration (IANR/CANR 2017). | Huang H et al. | β | 2018 | β |
| Common Gene Expression Patterns in the Generation of Induced Neurons From Fibroblasts. | Mohammadnia A et al. | β | 2018 | β |
| Concerns on "Dissection of Regulatory Elements During Direct Conversion of Somatic Cells Into Neurons" Paper. | Yaqubi M et al. | β | 2018 | β |
| Direct Conversion of Somatic Cells into Induced Neurons. | An N et al. | β | 2018 | β |
| Directing neuronal cell fate in vitro: Achievements and challenges. | Riemens RJM et al. | β | 2018 | β |
| Direct Reprogramming of Adult Human Somatic Stem Cells Into Functional Neurons Using <i>Sox2, Ascl1</i>, and <i>Neurog2</i>. | AraΓΊjo JAM et al. | β | 2018 | β |
| Direct Reprogramming of Spiral Ganglion Non-neuronal Cells into Neurons: Toward Ameliorating Sensorineural Hearing Loss by Gene Therapy. | Noda T et al. | β | 2018 | β |
| Diverse reprogramming codes for neuronal identity. | Tsunemoto R et al. | β | 2018 | β |
| Elixir of Life: Thwarting Aging With Regenerative Reprogramming. | Beyret E et al. | β | 2018 | β |
| Engineering new neurons: in vivo reprogramming in mammalian brain and spinal cord. | Wang LL et al. | β | 2018 | β |
| Establishment and Identification of a CiPSC Lineage Reprogrammed from FSP-tdTomato Mouse Embryonic Fibroblasts (MEFs). | Chen R et al. | β | 2018 | β |
| Generation of Functional Dopaminergic Neurons from Reprogramming Fibroblasts by Nonviral-based Mesoporous Silica Nanoparticles. | Chang JH et al. | β | 2018 | β |
| Genetics of Alcohol Use Disorder: A Role for Induced Pluripotent Stem Cells? | Prytkova I et al. | β | 2018 | β |
| Materials for Neural Differentiation, Trans-Differentiation, and Modeling of Neurological Disease. | Gong L et al. | β | 2018 | β |
| Mechanisms of Cortical Differentiation. | Adnani L et al. | β | 2018 | β |
| Mechanistic Insights Into MicroRNA-Induced Neuronal Reprogramming of Human Adult Fibroblasts. | Lu YL et al. | β | 2018 | β |
| miR-34b/c Regulates Wnt1 and Enhances Mesencephalic Dopaminergic Neuron Differentiation. | De Gregorio R et al. | β | 2018 | β |
| Modeling Neuropsychiatric and Neurodegenerative Diseases With Induced Pluripotent Stem Cells. | LaMarca EA et al. | β | 2018 | β |
| Nestin-expressing progenitor cells: function, identity and therapeutic implications. | Bernal A et al. | β | 2018 | β |
| Neural stem cell differentiation into mature neurons: Mechanisms of regulation and biotechnological applications. | Vieira MS et al. | β | 2018 | β |
| [Neuroregeneration by in vivo direct reprogramming]. | Izumi Y | β | 2018 | β |
| Parkinson-Associated SNCA Enhancer Variants Revealed by Open Chromatin in Mouse Dopamine Neurons. | McClymont SA et al. | β | 2018 | β |
| Parkinson's disease: what the model systems have taught us so far. | Ghatak S et al. | β | 2018 | β |
| Patient-Derived Induced Pluripotent Stem Cells and Organoids for Modeling Alpha Synuclein Propagation in Parkinson's Disease. | Koh YH et al. | β | 2018 | β |
| Phenotypic Reprogramming of Striatal Neurons into Dopaminergic Neuron-like Cells in the Adult Mouse Brain. | Niu W et al. | β | 2018 | β |
| Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects. | Sonntag KC et al. | β | 2018 | β |
| Potentials of Cellular Reprogramming as a Novel Strategy for Neuroregeneration. | Fang L et al. | β | 2018 | β |
| Repairing the Brain: Cell Replacement Using Stem Cell-Based Technologies. | Henchcliffe C et al. | β | 2018 | β |
| Representing Diversity in the Dish: Using Patient-Derived <i>in Vitro</i> Models to Recreate the Heterogeneity of Neurological Disease. | Ghaffari LT et al. | β | 2018 | β |
| Reprogramming Glia Into Neurons in the Peripheral Auditory System as a Solution for Sensorineural Hearing Loss: Lessons From the Central Nervous System. | Meas SJ et al. | β | 2018 | β |
| Reprogramming glioblastoma multiforme cells into neurons by protein kinase inhibitors. | Yuan J et al. | β | 2018 | β |
| Rotenone exerts developmental neurotoxicity in a human brain spheroid model. | Pamies D et al. | β | 2018 | β |
| Shaping Gene Expression by Landscaping Chromatin Architecture: Lessons from a Master. | Sartorelli V et al. | β | 2018 | β |
| Simple Generation of a High Yield Culture of Induced Neurons from Human Adult Skin Fibroblasts. | Shrigley S et al. | β | 2018 | β |
| Specific Cell (Re-)Programming: Approaches and Perspectives. | Hausburg F et al. | β | 2018 | β |
| Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease. | Dilliott AA et al. | β | 2018 | β |
| Towards stem cell based therapies for Parkinson's disease. | Parmar M | β | 2018 | β |
| Transdifferentiation of human adult peripheral blood T cells into neurons. | Tanabe K et al. | β | 2018 | β |
| Using Patient-Derived Induced Pluripotent Stem Cells to Identify Parkinson's Disease-Relevant Phenotypes. | Sison SL et al. | β | 2018 | β |
| A computational systems approach identifies synergistic specification genes that facilitate lineage conversion to prostate tissue. | Talos F et al. | β | 2017 | β |
| Adeno-Associated Viral Vectors Serotype 8 for Cell-Specific Delivery of Therapeutic Genes in the Central Nervous System. | Pignataro D et al. | β | 2017 | β |
| Advanced Gene Manipulation Methods for Stem Cell Theranostics. | Rathnam C et al. | β | 2017 | β |
| A molecular roadmap for induced multi-lineage trans-differentiation of fibroblasts by chemical combinations. | Han X et al. | β | 2017 | β |
| A mouse tissue transcription factor atlas. | Zhou Q et al. | β | 2017 | β |
| An update on stem cell biology and engineering for brain development. | Parr CJC et al. | β | 2017 | β |
| Applications of Tissue Engineering in Joint Arthroplasty: Current Concepts Update. | Zeineddine HA et al. | β | 2017 | β |
| Are reprogrammed cells a useful tool for studying dopamine dysfunction in psychotic disorders? A review of the current evidence. | Sauerzopf U et al. | β | 2017 | β |
| Back and forth in time: Directing age in iPSC-derived lineages. | Cornacchia D et al. | β | 2017 | β |
| Brain repair from intrinsic cell sources: Turning reactive glia into neurons. | Torper O et al. | β | 2017 | β |
| Cell fate modification toward the hepatic lineage by extrinsic factors. | Kawamata M et al. | β | 2017 | β |
| Cell reprogramming: Therapeutic potential and the promise of rejuvenation for the aging brain. | LΓ³pez-LeΓ³n M et al. | β | 2017 | β |
| Chemical reprogramming of mouse embryonic and adult fibroblast into endoderm lineage. | Cao S et al. | β | 2017 | β |
| Comparative gene expression study and pathway analysis of the human iris- and the retinal pigment epithelium. | Bennis A et al. | β | 2017 | β |
| Current status of treating neurodegenerative disease with induced pluripotent stem cells. | Pen AE et al. | β | 2017 | β |
| Direct conversion of human fibroblasts to functional excitatory cortical neurons integrating into human neural networks. | Miskinyte G et al. | β | 2017 | β |
| Direct induction of functional neuronal cells from fibroblast-like cells derived from adult human retina. | Hao L et al. | β | 2017 | β |
| Direct induction of neural progenitor cells transiently passes through a partially reprogrammed state. | Gao R et al. | β | 2017 | β |
| Directly reprogramming fibroblasts into adipogenic, neurogenic and hepatogenic differentiation lineages by defined factors. | Wu W et al. | β | 2017 | β |
| Direct Neuronal Reprogramming for Disease Modeling Studies Using Patient-Derived Neurons: What Have We Learned? | Drouin-Ouellet J et al. | β | 2017 | β |
| Direct Reprogramming of Resident NG2 Glia into Neurons with Properties of Fast-Spiking Parvalbumin-Containing Interneurons. | Pereira M et al. | β | 2017 | β |
| Direct Reprogramming Rather than iPSC-Based Reprogramming Maintains Aging Hallmarks in Human Motor Neurons. | Tang Y et al. | β | 2017 | β |
| Disrupted neuronal maturation in Angelman syndrome-derived induced pluripotent stem cells. | Fink JJ et al. | β | 2017 | β |
| Dissection of Regulatory Elements During Direct Conversion of Somatic Cells Into Neurons. | Soleimani T et al. | β | 2017 | β |
| Efficient Generation of Chemically Induced Mesenchymal Stem Cells from Human Dermal Fibroblasts. | Lai PL et al. | β | 2017 | β |
| Efficient Generation of Dopamine Neurons by Synthetic Transcription Factor mRNAs. | Kim SM et al. | β | 2017 | β |
| Electrophysiological properties of neurons derived from human stem cells and iNeurons inΒ vitro. | Halliwell RF | β | 2017 | β |
| Engineering cell identity: establishing new gene regulatory and chromatin landscapes. | Guo C et al. | β | 2017 | β |
| Evaluation of human dermal fibroblasts directly reprogrammed to adipocyte-like cells as a metabolic disease model. | Chen JH et al. | β | 2017 | β |
| Generation of Induced Progenitor-like Cells from Mature Epithelial Cells Using Interrupted Reprogramming. | Guo L et al. | β | 2017 | β |
| Generation of Integration-Free Induced Neurons Using Graphene Oxide-Polyethylenimine. | Baek S et al. | β | 2017 | β |
| Generation of pure GABAergic neurons by transcription factor programming. | Yang N et al. | β | 2017 | β |
| High content analysis in amyotrophic lateral sclerosis. | Rinaldi F et al. | β | 2017 | β |
| Human Induced Pluripotent Cell-Derived Sensory Neurons for Fate Commitment of Bone Marrow-Derived Schwann Cells: Implications for Remyelination Therapy. | Cai S et al. | β | 2017 | β |
| Identification of transcription factors that promote the differentiation of human pluripotent stem cells into lacrimal gland epithelium-like cells. | Hirayama M et al. | β | 2017 | β |
| Induced dopaminergic neurons: A new promise for Parkinson's disease. | Xu Z et al. | β | 2017 | β |
| Induced neural stem cells as a means of treatment in Huntington's disease. | Choi KA et al. | β | 2017 | β |
| Induction of functional dopamine neurons from human astrocytes in vitro and mouse astrocytes in a Parkinson's disease model. | Rivetti di Val Cervo P et al. | β | 2017 | β |
| Modelling APOE Ι3/4 allele-associated sporadic Alzheimer's disease in an induced neuron. | Kim H et al. | β | 2017 | β |
| Models of global gene expression define major domains of cell type and tissue identity. | Hutchins AP et al. | β | 2017 | β |
| Nanomaterials modulate stem cell differentiation: biological interaction and underlying mechanisms. | Wei M et al. | β | 2017 | β |
| Neuronal replacement therapy: previous achievements and challenges ahead. | Grade S et al. | β | 2017 | β |
| New approaches for direct conversion of patient fibroblasts into neural cells. | Gopalakrishnan S et al. | β | 2017 | β |
| New neurons in adult brain: distribution, molecular mechanisms and therapies. | Pino A et al. | β | 2017 | β |
| Old and new challenges in Parkinson's disease therapeutics. | Pires AO et al. | β | 2017 | β |
| Photoactivation of ERK/CREB/VMAT2 pathway attenuates MPP<sup>+</sup>-induced neuronal injury in a cellular model of Parkinson's disease. | Gu X et al. | β | 2017 | β |
| Programming and reprogramming the brain: a meeting of minds in neural fate. | GΓΆtz M et al. | β | 2017 | β |
| Regenerative therapy for hippocampal degenerative diseases: lessons from preclinical studies. | Venugopal C et al. | β | 2017 | β |
| Regulation of cAMP and GSK3 signaling pathways contributes to the neuronal conversion of glioma. | Oh J et al. | β | 2017 | β |
| Reprogramming cell fates by small molecules. | Ma X et al. | β | 2017 | β |
| Reprogramming of Pancreatic Acinar Cells to Functional Beta Cells by In Vivo Transduction of a Polycistronic Construct Containing Pdx1, Ngn3, MafA in Mice. | Cavelti-Weder C et al. | β | 2017 | β |
| Reprogramming of somatic cells: iPS and iN cells. | Broccoli V | β | 2017 | β |
| Reprogramming the diseased brain. | Dunnett SB et al. | β | 2017 | β |
| REST suppression mediates neural conversion of adult human fibroblasts via microRNA-dependent and -independent pathways. | Drouin-Ouellet J et al. | β | 2017 | β |
| Small molecules for reprogramming and transdifferentiation. | Qin H et al. | β | 2017 | β |
| Stem Cells for Modeling and Therapy of Parkinson's Disease. | Zhang Q et al. | β | 2017 | β |
| Stem cells for spinal cord injury: Strategies to inform differentiation and transplantation. | Iyer NR et al. | β | 2017 | β |
| Stem cell transplantation therapy for multifaceted therapeutic benefits after stroke. | Wei L et al. | β | 2017 | β |
| Studying human disease using human neurons. | Ahfeldt T et al. | β | 2017 | β |
| Targeted release of transcription factors for human cell reprogramming by ZEBRA cell-penetrating peptide. | Caulier B et al. | β | 2017 | β |
| Temporal establishment of neural cell identity in vivo and in vitro. | Yuen SM et al. | β | 2017 | β |
| The CDK8 Complex and Proneural Proteins Together Drive Neurogenesis from a Mesodermal Lineage. | Luo S et al. | β | 2017 | β |
| The expanding horizon of MicroRNAs in cellular reprogramming. | Adlakha YK et al. | β | 2017 | β |
| The Importance of Non-neuronal Cell Types in hiPSC-Based Disease Modeling and Drug Screening. | Gonzalez DM et al. | β | 2017 | β |
| The therapeutic potential of cell identity reprogramming for the treatment of aging-related neurodegenerative disorders. | Smith DK et al. | β | 2017 | β |
| The translational potential of humanΒ induced pluripotent stem cells for clinical neurology : The translational potential of hiPSCs in neurology. | Devine H et al. | β | 2017 | β |
| The zinc finger E-box-binding homeobox 1 (<i>Zeb1</i>) promotes the conversion of mouse fibroblasts into functional neurons. | Yan L et al. | β | 2017 | β |
| Transdifferentiation and reprogramming: Overview of the processes, their similarities and differences. | CieΕlar-Pobuda A et al. | β | 2017 | β |
| Transplantation in the nonhuman primate MPTP model of Parkinson's disease: update and perspectives. | Wianny F et al. | β | 2017 | β |
| Understanding neurodevelopmental disorders using human pluripotent stem cell-derived neurons. | Tamburini C et al. | β | 2017 | β |
| Understanding Parkinson's Disease through the Use of Cell Reprogramming. | Playne R et al. | β | 2017 | β |
| A Dishful of a Troubled Mind: Induced Pluripotent Stem Cells in Psychiatric Research. | KΓ‘lmΓ‘n S et al. | β | 2016 | β |
| Advances in Stem Cell Research- A Ray of Hope in Better Diagnosis and Prognosis in Neurodegenerative Diseases. | Singh S et al. | β | 2016 | β |
| A review of induced pluripotent stem cell, direct conversion by trans-differentiation, direct reprogramming and oligodendrocyte differentiation. | Prasad A et al. | β | 2016 | β |
| Asymmetric Regulation of Peripheral Genes by Two Transcriptional Regulatory Networks. | Li JR et al. | β | 2016 | β |
| Bioinformatic and Genomic Analyses of Cellular Reprogramming and Direct Lineage Conversion. | Kareta MS | β | 2016 | β |
| Brain repair and reprogramming: the route to clinical translation. | Grealish S et al. | β | 2016 | β |
| Breaking dogma for future therapy using stem cell - Where we have reached? | Verma RS | β | 2016 | β |
| Cardiac Niche Influences the Direct Reprogramming of Canine Fibroblasts into Cardiomyocyte-Like Cells. | Palazzolo G et al. | β | 2016 | β |
| Clinical translation of stem cell transplantation in Parkinson's disease. | Lindvall O | β | 2016 | β |
| Clinical Trials in a Dish: The Potential of Pluripotent Stem Cells to Develop Therapies for Neurodegenerative Diseases. | Haston KM et al. | β | 2016 | β |
| Conversion of adult human peripheral blood mononuclear cells into induced neural stem cell by using episomal vectors. | Tang X et al. | β | 2016 | β |
| Conversion of Fibroblasts to Parvalbumin Neurons by One Transcription Factor, Ascl1, and the Chemical Compound Forskolin. | Shi Z et al. | β | 2016 | β |
| Direct cell fate conversion of human somatic stem cells into cone and rod photoreceptor-like cells by inhibition of microRNA-203. | Choi SW et al. | β | 2016 | β |
| Direct conversion of human fibroblasts to induced serotonergic neurons. | Xu Z et al. | β | 2016 | β |
| Direct Induction and Functional Maturation of Forebrain GABAergic Neurons from Human Pluripotent Stem Cells. | Sun AX et al. | β | 2016 | β |
| Direct Lineage Reprogramming Reveals Disease-Specific Phenotypes of Motor Neurons from Human ALS Patients. | Liu ML et al. | β | 2016 | β |
| Direct lineage reprogramming via pioneer factors; a detour through developmental gene regulatory networks. | Morris SA | β | 2016 | β |
| Direct neuronal reprogramming: learning from and for development. | Masserdotti G et al. | β | 2016 | β |
| Direct reprogramming and biomaterials for controlling cell fate. | Kim E et al. | β | 2016 | β |
| Direct reprogramming of somatic cells into neural stem cells or neurons for neurological disorders. | Hou S et al. | β | 2016 | β |
| Disease signatures for schizophrenia and bipolar disorder using patient-derived induced pluripotent stem cells. | Watmuff B et al. | β | 2016 | β |
| Dissecting direct reprogramming from fibroblast to neuron using single-cell RNA-seq. | Treutlein B et al. | β | 2016 | β |
| Drosophila eye developmental defect caused by elevation of the activity of the LIM-homeodomain protein, Lmx1a, requires its association with the Co-activator Chip. | Wang P et al. | β | 2016 | β |
| Effects of continuous wave and fractionated diode laser on human fibroblast cancer and dermal normal cells by zinc phthalocyanine in photodynamic therapy: A comparative study. | Navaeipour F et al. | β | 2016 | β |
| Efficient generation of dopaminergic-like neurons by overexpression of Nurr1 and Pitx3 in mouse induced Pluripotent Stem Cells. | Salemi S et al. | β | 2016 | β |
| Engineering personalized neural tissue using functionalized transcription factors. | Willerth SM | β | 2016 | β |
| Epigenetic Conversion as a Safe and Simple Method to Obtain Insulin-secreting Cells from Adult Skin Fibroblasts. | Brevini TA et al. | β | 2016 | β |
| Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience. | Mertens J et al. | β | 2016 | β |
| Experimental Advances Towards Neural Regeneration from Induced Stem Cells to Direct In Vivo Reprogramming. | Dametti S et al. | β | 2016 | β |
| Exploiting the potential of next-generation sequencing in genomic medicine. | Pinto AM et al. | β | 2016 | β |
| FoxO3 regulates neuronal reprogramming of cells from postnatal and aging mice. | Ahlenius H et al. | β | 2016 | β |
| Functional hyaluronate collagen scaffolds induce NSCs differentiation into functional neurons in repairing the traumatic brain injury. | Duan H et al. | β | 2016 | β |
| Generating Diverse Spinal Motor Neuron Subtypes from Human Pluripotent Stem Cells. | Patani R | β | 2016 | β |
| Generating human serotonergic neurons in vitro: Methodological advances. | Vadodaria KC et al. | β | 2016 | β |
| Generation of diverse neural cell types through direct conversion. | Petersen GF et al. | β | 2016 | β |
| Generation of functional human serotonergic neurons from fibroblasts. | Vadodaria KC et al. | β | 2016 | β |
| Generation of Integration-free Induced Neural Stem Cells from Mouse Fibroblasts. | Kim SM et al. | β | 2016 | β |
| Induced neural stem cells from distinct genetic backgrounds exhibit different reprogramming status. | Kim SM et al. | β | 2016 | β |
| Induced Pluripotent Stem Cells as a Novel Tool in Psychiatric Research. | Kim S et al. | β | 2016 | β |
| Induced Pluripotent Stem Cells: Generation Strategy and Epigenetic Mystery behind Reprogramming. | Ji P et al. | β | 2016 | β |
| Induction of specific neuron types by overexpression of single transcription factors. | Teratani-Ota Y et al. | β | 2016 | β |
| Interstitial 1q23.3q24.1 deletion in a patient with renal malformation, congenital heart disease, and mild intellectual disability. | Mackenroth L et al. | β | 2016 | β |
| InΒ Vivo Cellular Reprogramming: The Next Generation. | Srivastava D et al. | β | 2016 | β |
| InΒ Vivo Reprogramming for CNS Repair: Regenerating Neurons from Endogenous Glial Cells. | Li H et al. | β | 2016 | β |
| iPSCs: On the Road to Reprogramming Aging. | Soria-Valles C et al. | β | 2016 | β |
| Lmx1a and Lmx1b regulate mitochondrial functions and survival of adult midbrain dopaminergic neurons. | Doucet-BeauprΓ© H et al. | β | 2016 | β |
| Migration of bone marrow progenitor cells in the adult brain of rats and rabbits. | Dennie D et al. | β | 2016 | β |
| miR-124-9-9* potentiates Ascl1-induced reprogramming of cultured MΓΌller glia. | Wohl SG et al. | β | 2016 | β |
| Nano and microcarriers to improve stem cell behaviour for neuroregenerative medicine strategies: Application to Huntington's disease. | AndrΓ© EM et al. | β | 2016 | β |
| Neuroprotective Transcription Factors in Animal Models of Parkinson Disease. | Blaudin de ThΓ© FX et al. | β | 2016 | β |
| PAF-Wnt signaling-induced cell plasticity is required for maintenance of breast cancer cell stemness. | Wang X et al. | β | 2016 | β |
| Physiological, pathological, and engineered cell identity reprogramming in the central nervous system. | Smith DK et al. | β | 2016 | β |
| Plasmid-Based Generation of Induced Neural Stem Cells from Adult Human Fibroblasts. | Capetian P et al. | β | 2016 | β |
| Pluripotent stem cell derived hepatocytes: using materials to define cellular differentiation and tissue engineering. | Lucendo-Villarin B et al. | β | 2016 | β |
| Progress and Challenges of Cell Replacement Therapy for Neurodegenerative Diseases Based on Direct Neural Reprogramming. | Chen Y et al. | β | 2016 | β |
| Rapid and efficient CRISPR/Cas9 gene inactivation in human neurons during human pluripotent stem cell differentiation and direct reprogramming. | Rubio A et al. | β | 2016 | β |
| Recent Progress in Cell Reprogramming Technology for Cell Transplantation Therapy. | Yamashita T et al. | β | 2016 | β |
| Reprogramming A375 cells to inducedβresembled neuronal cells by structured overexpression of specific transcription genes. | Zhang H et al. | β | 2016 | β |
| RNAi-mediated silencing of HLA A2 suppressed acute rejection against human fibroblast xenografts in the striatum of 6-OHDA lesioned rats. | Liang C et al. | β | 2016 | β |
| Role of Hepatic-Specific Transcription Factors and Polycomb Repressive Complex 2 during Induction of Fibroblasts to Hepatic Fate. | Rastegar-Pouyani S et al. | β | 2016 | β |
| Role of Nurr1 in the Generation and Differentiation of Dopaminergic Neurons from Stem Cells. | RodrΓguez-Traver E et al. | β | 2016 | β |
| Role of SATB2 in human pancreatic cancer: Implications in transformation and a promising biomarker. | Yu W et al. | β | 2016 | β |
| Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells. | Xue Y et al. | β | 2016 | β |
| Signal transduction of the physical environment in the neural differentiation of stem cells. | Thompson R et al. | β | 2016 | β |
| Small-Molecule-Based Lineage Reprogramming Creates Functional Astrocytes. | Tian E et al. | β | 2016 | β |
| Small Molecules Facilitate Single Factor-Mediated Hepatic Reprogramming. | Lim KT et al. | β | 2016 | β |
| Stem Cell-Mediated Regeneration of the Adult Brain. | Jessberger S | β | 2016 | β |
| Stem Cells in Neurotoxicology/Developmental Neurotoxicology: Current Scenario and Future Prospects. | Singh S et al. | β | 2016 | β |
| TGFΞ² signaling regulates the choice between pluripotent and neural fates during reprogramming of human urine derived cells. | Wang L et al. | β | 2016 | β |
| Therapeutical Strategies for Spinal Cord Injury and a Promising Autologous Astrocyte-Based Therapy Using Efficient Reprogramming Techniques. | Yang H et al. | β | 2016 | β |
| Therapeutic transdifferentiation of human fibroblasts into endothelial cells using forced expression of lineage-specific transcription factors. | Wong WT et al. | β | 2016 | β |
| Transplantation of human induced cerebellar granular-like cells improves motor functions in a novel mouse model of cerebellar ataxia. | Zhu T et al. | β | 2016 | β |
| Triboelectric Nanogenerator Accelerates Highly Efficient Nonviral Direct Conversion and In Vivo Reprogramming of Fibroblasts to Functional Neuronal Cells. | Jin Y et al. | β | 2016 | β |
| (124)I-PET Assessment of Human Sodium Iodide Symporter Reporter Gene Activity for Highly Sensitive In Vivo Monitoring of Teratoma Formation in Mice. | Lehner S et al. | β | 2015 | β |
| Altered gene expression in schizophrenia: findings from transcriptional signatures in fibroblasts and blood. | Cattane N et al. | β | 2015 | β |
| Ascl1 Converts Dorsal Midbrain Astrocytes into Functional Neurons In Vivo. | Liu Y et al. | β | 2015 | β |
| Autologous iPSC-derived dopamine neuron transplantation in a nonhuman primate Parkinson's disease model. | Wang S et al. | β | 2015 | β |
| Blood transcriptomics of drug-naΓ―ve sporadic Parkinson's disease patients. | Calligaris R et al. | β | 2015 | β |
| Cell-based therapies for Parkinson diseaseβpast insights and future potential. | Barker RA et al. | β | 2015 | β |
| Cell cycle and p53 gate the direct conversion of human fibroblasts to dopaminergic neurons. | Jiang H et al. | β | 2015 | β |
| Cell fate determination, neuronal maintenance and disease state: The emerging role of transcription factors Lmx1a and Lmx1b. | Doucet-BeauprΓ© H et al. | β | 2015 | β |
| Cell Therapy for Parkinson's Disease: New Hope from Reprogramming Technologies. | Chen Z | β | 2015 | β |
| CEND1 and NEUROGENIN2 Reprogram Mouse Astrocytes and Embryonic Fibroblasts to Induced Neural Precursors and Differentiated Neurons. | Aravantinou-Fatorou K et al. | β | 2015 | β |
| Clinical utility of neuronal cells directly converted from fibroblasts of patients for neuropsychiatric disorders: studies of lysosomal storage diseases and channelopathy. | Kano S et al. | β | 2015 | β |
| Connectivity and circuitry in a dish versus in a brain. | Chinchalongporn V et al. | β | 2015 | β |
| Derivation of Adult Human Fibroblasts and their Direct Conversion into Expandable Neural Progenitor Cells. | Meyer S et al. | β | 2015 | β |
| Development of stem cell-based therapy for Parkinson's disease. | Han F et al. | β | 2015 | β |
| Direct cardiac reprogramming: progress and challenges in basic biology and clinical applications. | Sadahiro T et al. | β | 2015 | β |
| Direct Conversion of Cord Blood CD34+ Cells Into Neural Stem Cells by OCT4. | Liao W et al. | β | 2015 | β |
| Direct conversion of fibroblasts into functional astrocytes by defined transcription factors. | Caiazzo M et al. | β | 2015 | β |
| Direct conversion of human fibroblasts into dopaminergic neural progenitor-like cells using TAT-mediated protein transduction of recombinant factors. | Mirakhori F et al. | β | 2015 | β |
| Direct conversion of mouse fibroblasts to GABAergic neurons with combined medium without the introduction of transcription factors or miRNAs. | Xu H et al. | β | 2015 | β |
| Direct Conversion of Normal and Alzheimer's Disease Human Fibroblasts into Neuronal Cells by Small Molecules. | Hu W et al. | β | 2015 | β |
| Direct lineage conversion of astrocytes to induced neural stem cells or neurons. | Huang Y et al. | β | 2015 | β |
| Direct lineage reprogramming: strategies, mechanisms, and applications. | Xu J et al. | β | 2015 | β |
| Direct Reprogramming for Pancreatic Beta-Cells Using Key Developmental Genes. | Cavelti-Weder C et al. | β | 2015 | β |
| Direct Reprogramming-The Future of Cardiac Regeneration? | Doppler SA et al. | β | 2015 | β |
| Direct somatic lineage conversion. | Tanabe K et al. | β | 2015 | β |
| Dopaminergic differentiation of schizophrenia hiPSCs. | Hartley BJ et al. | β | 2015 | β |
| Efficient differentiation of human embryonic stem cells toward dopaminergic neurons using recombinant LMX1A factor. | Fathi A et al. | β | 2015 | β |
| Enhanced differentiation of neural progenitor cells into neurons of the mesencephalic dopaminergic subtype on topographical patterns. | Tan KK et al. | β | 2015 | β |
| Enhanced MyoD-induced transdifferentiation to a myogenic lineage by fusion to a potent transactivation domain. | Kabadi AM et al. | β | 2015 | β |
| FGF8 is Essential for Functionality of Induced Neural Precursor Cell-derived Dopaminergic Neurons. | Lim MS et al. | β | 2015 | β |
| Forward engineering neuronal diversity using direct reprogramming. | Tsunemoto RK et al. | β | 2015 | β |
| From "directed differentiation" to "neuronal induction": modeling neuropsychiatric disease. | Ho SM et al. | β | 2015 | β |
| Generation of integration-free induced hepatocyte-like cells from mouse fibroblasts. | Kim J et al. | β | 2015 | β |
| Generation of primitive neural stem cells from human fibroblasts using a defined set of factors. | Miura T et al. | β | 2015 | β |
| Homogeneous generation of iDA neurons with high similarity to bona fide DA neurons using a drug inducible system. | Park H et al. | β | 2015 | β |
| How to make a midbrain dopaminergic neuron. | Arenas E et al. | β | 2015 | β |
| How to make neurons--thoughts on the molecular logic of neurogenesis in the central nervous system. | Ninkovic J et al. | β | 2015 | β |
| Human induced pluripotent stem cell and nanotechnology-based therapeutics. | Liu WH et al. | β | 2015 | β |
| Importance of being Nernst: Synaptic activity and functional relevance in stem cell-derived neurons. | Bradford AB et al. | β | 2015 | β |
| Induced pluripotent stem cell-derived neural stem cell therapies for spinal cord injury. | Lee-Kubli CA et al. | β | 2015 | β |
| [Inducing brain regeneration from within: in vivo reprogramming of endogenous somatic cells into neurons]. | Heinrich C et al. | β | 2015 | β |
| Induction of neural tissue markers by micronized human spinal cord implants. | Carpenter EM et al. | β | 2015 | β |
| In Vivo Reprogramming for Brain and Spinal Cord Repair. | Chen G et al. | β | 2015 | β |
| In vivo reprogramming for tissue repair. | Heinrich C et al. | β | 2015 | β |
| In Vivo Reprogramming of Striatal NG2 Glia into Functional Neurons that Integrate into Local Host Circuitry. | Torper O et al. | β | 2015 | β |
| Large-Scale Nanoelectrode Arrays to Monitor the Dopaminergic Differentiation of Human Neural Stem Cells. | Kim TH et al. | β | 2015 | β |
| Limitations of In Vivo Reprogramming to Dopaminergic Neurons via a Tricistronic Strategy. | Theodorou M et al. | β | 2015 | β |
| limma powers differential expression analyses for RNA-sequencing and microarray studies. | Ritchie ME et al. | β | 2015 | β |
| Lmx1a enhances the effect of iNSCs in a PD model. | Wu J et al. | β | 2015 | β |
| MASH1/Ascl1a leads to GAP43 expression and axon regeneration in the adult CNS. | Williams RR et al. | β | 2015 | β |
| MicroRNA-based conversion of human fibroblasts into striatal medium spiny neurons. | Richner M et al. | β | 2015 | β |
| MicroRNA-Mediated In Vitro and In Vivo Direct Conversion of Astrocytes to Neuroblasts. | Ghasemi-Kasman M et al. | β | 2015 | β |
| Mitochondrial iron and energetic dysfunction distinguish fibroblasts and induced neurons from pantothenate kinase-associated neurodegeneration patients. | Santambrogio P et al. | β | 2015 | β |
| Multi-site phospho-regulation of proneural transcription factors controls proliferation versus differentiation in development and reprogramming. | Philpott A | β | 2015 | β |
| Nanogrooved substrate promotes direct lineage reprogramming of fibroblasts to functional induced dopaminergic neurons. | Yoo J et al. | β | 2015 | β |
| Neurogenin 2 enhances the generation of patient-specific induced neuronal cells. | Zhao P et al. | β | 2015 | β |
| Neuronal medium that supports basic synaptic functions and activity of human neurons in vitro. | Bardy C et al. | β | 2015 | β |
| Overcoming the hurdles for a reproducible generation of human functionally mature reprogrammed neurons. | Broccoli V et al. | β | 2015 | β |
| PINK1 and Parkin control localized translation of respiratory chain component mRNAs on mitochondria outer membrane. | Gehrke S et al. | β | 2015 | β |
| Predicting involvement of polycomb repressive complex 2 in direct conversion of mouse fibroblasts into induced neural stem cells. | Yaqubi M et al. | β | 2015 | β |
| Probing disorders of the nervous system using reprogramming approaches. | Ichida JK et al. | β | 2015 | β |
| Probing stem cell behavior using nanoparticle-based approaches. | Patel S et al. | β | 2015 | β |
| Programming and reprogramming a human heart cell. | Sahara M et al. | β | 2015 | β |
| Rapid Conversion of Fibroblasts into Functional Forebrain GABAergic Interneurons by Direct Genetic Reprogramming. | Colasante G et al. | β | 2015 | β |
| Regeneration through reprogramming adult cell identity in vivo. | Smith DK et al. | β | 2015 | β |
| Regulation of stem cell fate by nanomaterial substrates. | Mashinchian O et al. | β | 2015 | β |
| Reprogrammed Functional Brown Adipocytes Ameliorate Insulin Resistance and Dyslipidemia in Diet-Induced Obesity and Type 2 Diabetes. | Kishida T et al. | β | 2015 | β |
| Selective conversion of fibroblasts into peripheral sensory neurons. | Blanchard JW et al. | β | 2015 | β |
| Selective Generation of Dopaminergic Precursors from Mouse Fibroblasts by Direct Lineage Conversion. | Tian C et al. | β | 2015 | β |
| Small-Molecule-Driven Direct Reprogramming of Mouse Fibroblasts into Functional Neurons. | Li X et al. | β | 2015 | β |
| SOX2 and SOX2-MYC Reprogramming Process of Fibroblasts to the Neural Stem Cells Compromised by Senescence. | Winiecka-Klimek M et al. | β | 2015 | β |
| Stem cell reprogramming: basic implications and future perspective for movement disorders. | BrΓ€ndl B et al. | β | 2015 | β |
| Stem Cells in Neurological Disorders: Emerging Therapy with Stunning Hopes. | Upadhyay G et al. | β | 2015 | β |
| The State of Play with iPSCs and Spinal Cord Injury Models. | Hodgetts SI et al. | β | 2015 | β |
| Transdifferentiation of Fibroblasts by Defined Factors. | Zhao Z et al. | β | 2015 | β |
| Transdifferentiation via transcription factors or microRNAs: Current status and perspective. | Wang H et al. | β | 2015 | β |
| Treatment of Parkinson's disease using cell transplantation. | Lindvall O | β | 2015 | β |
| Tumor cells undergoing direct lineage conversion to neurons: unnatural but useful? | Jiang YY et al. | β | 2015 | β |
| Activation of neural cell fate programs toward direct conversion of adult human fibroblasts into tri-potent neural progenitors using OCT-4. | Mitchell RR et al. | β | 2014 | β |
| Adult-derived pluripotent stem cells. | Faulkner SD et al. | β | 2014 | β |
| A promising approach to iPSC-based cell therapy for diabetic wound treatment: direct lineage reprogramming. | Li S et al. | β | 2014 | β |
| A rapid and sensitive automated image-based approach for in vitro and in vivo characterization of cell morphology and quantification of cell number and neurite architecture. | Tapias V et al. | β | 2014 | β |
| A stochastic model dissects cell states in biological transition processes. | Armond JW et al. | β | 2014 | β |
| A transient disruption of fibroblastic transcriptional regulatory network facilitates trans-differentiation. | Tomaru Y et al. | β | 2014 | β |
| bHLH factors in self-renewal, multipotency, and fate choice of neural progenitor cells. | Imayoshi I et al. | β | 2014 | β |
| Bio-inspired hybrid microelectrodes: a hybrid solution to improve long-term performance of chronic intracortical implants. | De Faveri S et al. | β | 2014 | β |
| Cell based therapies for ischemic stroke: from basic science to bedside. | Liu X et al. | β | 2014 | β |
| CellNet: network biology applied to stem cell engineering. | Cahan P et al. | β | 2014 | β |
| CellNet--where your cells are standing. | Kim KP et al. | β | 2014 | β |
| Concise review: Generation of neurons from somatic cells of healthy individuals and neurological patients through induced pluripotency or direct conversion. | Velasco I et al. | β | 2014 | β |
| Conversion of fibroblasts to neural cells by p53 depletion. | Zhou D et al. | β | 2014 | β |
| Development-inspired reprogramming of the mammalian central nervous system. | Amamoto R et al. | β | 2014 | β |
| Differentiated type II pneumocytes can be reprogrammed by ectopic Sox2 expression. | Kapere Ochieng J et al. | β | 2014 | β |
| Direct conversion of human fibroblasts into neuronal restricted progenitors. | Zou Q et al. | β | 2014 | β |
| Direct conversion of mouse and human fibroblasts to functional melanocytes by defined factors. | Yang R et al. | β | 2014 | β |
| Direct conversion of mouse fibroblasts into induced neural stem cells. | Kim SM et al. | β | 2014 | β |
| Directed midbrain and spinal cord neurogenesis from pluripotent stem cells to model development and disease in a dish. | Allodi I et al. | β | 2014 | β |
| Direct lineage reprogramming of mouse fibroblasts to functional midbrain dopaminergic neuronal progenitors. | Kim HS et al. | β | 2014 | β |
| Direct neural conversion from human fibroblasts using self-regulating and nonintegrating viral vectors. | Lau S et al. | β | 2014 | β |
| Direct reprogrammed neuronal cells as a novel resource for cell transplantation therapy. | Yamashita T et al. | β | 2014 | β |
| Dopaminergic-like neurons derived from oral mucosa stem cells by developmental cues improve symptoms in the hemi-parkinsonian rat model. | Ganz J et al. | β | 2014 | β |
| Dyskinesia in Parkinson's disease: mechanisms and current non-pharmacological interventions. | Heumann R et al. | β | 2014 | β |
| Dysregulation of gene expression as a cause of Cockayne syndrome neurological disease. | Wang Y et al. | β | 2014 | β |
| Efficient reprogramming of mouse fibroblasts to neuronal cells including dopaminergic neurons. | Oh SI et al. | β | 2014 | β |
| Electrophysiological profiles of induced neurons converted directly from adult human fibroblasts indicate incomplete neuronal conversion. | Koppensteiner P et al. | β | 2014 | β |
| Enhancing the efficiency of direct reprogramming of human primary fibroblasts into dopaminergic neuron-like cells through p53 suppression. | Liu X et al. | β | 2014 | β |
| Evolving toward a human-cell based and multiscale approach to drug discovery for CNS disorders. | Schadt EE et al. | β | 2014 | β |
| Fast and efficient neural conversion of human hematopoietic cells. | CastaΓ±o J et al. | β | 2014 | β |
| From induction to conduction: how intrinsic transcriptional priming of extrinsic neuronal connectivity shapes neuronal identity. | Russ JB et al. | β | 2014 | β |
| Functional differentiation of midbrain neurons from human cord blood-derived induced pluripotent stem cells. | Stanslowsky N et al. | β | 2014 | β |
| Functional roles of Nurr1, Pitx3, and Lmx1a in neurogenesis and phenotype specification of dopamine neurons during in vitro differentiation of embryonic stem cells. | Hong S et al. | β | 2014 | β |
| Generating human neurons in vitro and using them to understand neuropsychiatric disease. | PaΕca SP et al. | β | 2014 | β |
| Generation of human striatal neurons by microRNA-dependent direct conversion of fibroblasts. | Victor MB et al. | β | 2014 | β |
| Generation of induced neuronal cells by the single reprogramming factor ASCL1. | Chanda S et al. | β | 2014 | β |
| Generation of patient-specific induced neuronal cells using a direct reprogramming strategy. | Wang P et al. | β | 2014 | β |
| Highly efficient generation of induced neurons from human fibroblasts that survive transplantation into the adult rat brain. | Pereira M et al. | β | 2014 | β |
| Human pluripotent stem cell-derived cardiomyocytes as research and therapeutic tools. | Acimovic I et al. | β | 2014 | β |
| Human stem cell models of neurodegeneration: a novel approach to study mechanisms of disease development. | Hargus G et al. | β | 2014 | β |
| Increased expression of dopamine receptors in synovial fibroblasts from patients with rheumatoid arthritis: inhibitory effects of dopamine on interleukin-8 and interleukin-6. | Capellino S et al. | β | 2014 | β |
| Induced neural lineage cells as repair kits: so close, yet so far away. | Mirakhori F et al. | β | 2014 | β |
| Induced neural stem cells: methods of reprogramming and potential therapeutic applications. | Ruggieri M et al. | β | 2014 | β |
| Induced neuronal reprogramming. | Ang CE et al. | β | 2014 | β |
| Induced pluripotent stem cell potential in medicine, specifically focused on reproductive medicine. | Botman O et al. | β | 2014 | β |
| Instant neurons: directed somatic cell reprogramming models of central nervous system disorders. | Qiang L et al. | β | 2014 | β |
| In vivo direct reprogramming of reactive glial cells into functional neurons after brain injury and in an Alzheimer's disease model. | Guo Z et al. | β | 2014 | β |
| In vivo reprogramming of pancreatic acinar cells to three islet endocrine subtypes. | Li W et al. | β | 2014 | β |
| Lineage-reprogramming of pericyte-derived cells of the adult human brain into induced neurons. | Karow M et al. | β | 2014 | β |
| Maintaining the pluripotency of mouse embryonic stem cells on gold nanoparticle layers with nanoscale but not microscale surface roughness. | Lyu Z et al. | β | 2014 | β |
| Mash1 efficiently reprograms rat astrocytes into neurons. | Ding D et al. | β | 2014 | β |
| Modeling heterogeneous patients with a clinical diagnosis of schizophrenia with induced pluripotent stem cells. | Brennand KJ et al. | β | 2014 | β |
| Modeling human neurological disorders with induced pluripotent stem cells. | Imaizumi Y et al. | β | 2014 | β |
| Molecular mechanisms of dopaminergic subset specification: fundamental aspects and clinical perspectives. | Veenvliet JV et al. | β | 2014 | β |
| Morphological and molecular changes of human granulosa cells exposed to 5-azacytidine and addressed toward muscular differentiation. | Brevini TA et al. | β | 2014 | β |
| Nurr1 expression is regulated by voltage-dependent calcium channels and calcineurin in cultured hippocampal neurons. | Tokuoka H et al. | β | 2014 | β |
| Over-expression of Oct4 and Sox2 transcription factors enhances differentiation of human umbilical cord blood cells in vivo. | Guseva D et al. | β | 2014 | β |
| Pioneer transcription factors in cell reprogramming. | Iwafuchi-Doi M et al. | β | 2014 | β |
| Pluripotent reprogramming and lineage reprogramming: promises and challenges in cardiovascular regeneration. | He WJ et al. | β | 2014 | β |
| Potential for cell therapy in Parkinson's disease using genetically programmed human embryonic stem cell-derived neural progenitor cells. | Ambasudhan R et al. | β | 2014 | β |
| Proneural bHLH genes in development and disease. | Huang C et al. | β | 2014 | β |
| Proneural transcription factor Atoh1 drives highly efficient differentiation of human pluripotent stem cells into dopaminergic neurons. | Sagal J et al. | β | 2014 | β |
| Prospects for engineering neurons from local neocortical cell populations as cell-mediated therapy for neurological disorders. | Bazarek S et al. | β | 2014 | β |
| Proteomic profiling of cardiac tissue by isolation of nuclei tagged in specific cell types (INTACT). | Amin NM et al. | β | 2014 | β |
| Regenerative Medicine for the Aging Brain. | Lopez-Leon M et al. | β | 2014 | β |
| Remote control of induced dopaminergic neurons in parkinsonian rats. | Dell'Anno MT et al. | β | 2014 | β |
| Repositioning monocyte TFRN into fibroblasts. | Suzuki T et al. | β | 2014 | β |
| Reprogramming cell fate: a changing story. | Chin MT | β | 2014 | β |
| Reprogramming non-human primate somatic cells into functional neuronal cells by defined factors. | Zhou Z et al. | β | 2014 | β |
| Reprogramming of pig dermal fibroblast into insulin secreting cells by a brief exposure to 5-aza-cytidine. | Pennarossa G et al. | β | 2014 | β |
| Reprogramming sertoli cells into pluripotent stem cells. | Sun H et al. | β | 2014 | β |
| Retinoic acid receptor Ξ³ (Rarg) and nuclear receptor subfamily 5, group A, member 2 (Nr5a2) promote conversion of fibroblasts to functional neurons. | Shi Z et al. | β | 2014 | β |
| Senescence impairs direct conversion of human somatic cells to neurons. | Sun CK et al. | β | 2014 | β |
| Signaling adaptor protein SH2B1 enhances neurite outgrowth and accelerates the maturation of human induced neurons. | Hsu YC et al. | β | 2014 | β |
| Somatic Cell Reprogramming into Cardiovascular Lineages. | Chen JX et al. | β | 2014 | β |
| Stem cells and the treatment of Parkinson's disease. | Ali F et al. | β | 2014 | β |
| The effect of substrate topography on direct reprogramming of fibroblasts to induced neurons. | Kulangara K et al. | β | 2014 | β |
| The future of cell therapies and brain repair: Parkinson's disease leads the way. | Petit GH et al. | β | 2014 | β |
| The phosphorylation status of Ascl1 is a key determinant of neuronal differentiation and maturation in vivo and in vitro. | Ali FR et al. | β | 2014 | β |
| The Potential for iPS-Derived Stem Cells as a Therapeutic Strategy for Spinal Cord Injury: Opportunities and Challenges. | Khazaei M et al. | β | 2014 | β |
| The potential of alternate sources of cells for neural grafting in Parkinson's and Huntington's disease. | Drouin-Ouellet J | β | 2014 | β |
| The Power and the Promise of Cell Reprogramming: Personalized Autologous Body Organ and Cell Transplantation. | Palomo AB et al. | β | 2014 | β |
| Translation: screening for novel therapeutics with disease-relevant cell types derived from human stem cell models. | Haggarty SJ et al. | β | 2014 | β |
| Treating Parkinson's disease in the 21st century: can stem cell transplantation compete? | Buttery PC et al. | β | 2014 | β |
| Tuning cell fate: from insights to vertebrate regeneration. | Kami D et al. | β | 2014 | β |
| When norepinephrine becomes a driver of breathing irregularities: how intermittent hypoxia fundamentally alters the modulatory response of the respiratory network. | Zanella S et al. | β | 2014 | β |
| Wnts enhance neurotrophin-induced neuronal differentiation in adult bone-marrow-derived mesenchymal stem cells via canonical and noncanonical signaling pathways. | Tsai HL et al. | β | 2014 | β |
| Wnt signaling in midbrain dopaminergic neuron development and regenerative medicine for Parkinson's disease. | Arenas E | β | 2014 | β |
| A blueprint for engineering cell fate: current technologies to reprogram cell identity. | Morris SA et al. | β | 2013 | β |
| Advances in culture and manipulation of human pluripotent stem cells. | Qian X et al. | β | 2013 | β |
| A Gata3-Mafb transcriptional network directs post-synaptic differentiation in synapses specialized for hearing. | Yu WM et al. | β | 2013 | β |
| A novel approach to facilitate dopaminergic neuron generation from stem-cells: the combination of genetic modification and signaling factors within a three-dimensional perfusion microbioreactor. | Song L et al. | β | 2013 | β |
| At a crossroad: cell therapy for cardiac repair. | Deutsch MA et al. | β | 2013 | β |
| Automated imaging system for fast quantitation of neurons, cell morphology and neurite morphometry in vivo and in vitro. | Tapias V et al. | β | 2013 | β |
| Cell therapy: the final frontier for treatment of neurological diseases. | Dutta S et al. | β | 2013 | β |
| Changes in brainstem serotonergic and dopaminergic cell populations in experimental and clinical Huntington's disease. | Jahanshahi A et al. | β | 2013 | β |
| Characterization of induced neural progenitors from skin fibroblasts by a novel combination of defined factors. | Tian C et al. | β | 2013 | β |
| Chemical approaches to stem cell biology and therapeutics. | Li W et al. | β | 2013 | β |
| Conversion of pericytes to neurons: a new guest at the reprogramming convention. | Nivet E et al. | β | 2013 | β |
| Defining the diversity of phenotypic respecification using multiple cell lines and reprogramming regimens. | Alicea B et al. | β | 2013 | β |
| Developing dopaminergic cell therapy for Parkinson's disease--give up or move forward? | Lindvall O | β | 2013 | β |
| Direct conversion of adipocyte progenitors into functional neurons. | Yang Y et al. | β | 2013 | β |
| Direct conversion of fibroblasts into neural progenitor-like cells by forced growth into 3D spheres on low attachment surfaces. | Su G et al. | β | 2013 | β |
| Direct conversion of fibroblasts to neurons by reprogramming PTB-regulated microRNA circuits. | Xue Y et al. | β | 2013 | β |
| Direct reprogramming into desired cell types by defined factors. | Ieda M | β | 2013 | β |
| Direct reprogramming of adult somatic cells into other lineages: past evidence and future perspectives. | Nizzardo M et al. | β | 2013 | β |
| Direct reprogramming of mouse fibroblasts into cardiac myocytes. | Inagawa K et al. | β | 2013 | β |
| Dopamine D2 receptor-mediated epidermal growth factor receptor transactivation through a disintegrin and metalloprotease regulates dopaminergic neuron development via extracellular signal-related kinase activation. | Yoon S et al. | β | 2013 | β |
| Environmental impact on direct neuronal reprogramming in vivo in the adult brain. | Grande A et al. | β | 2013 | β |
| Epidermal stem cells: an update on their potential in regenerative medicine. | Sun X et al. | β | 2013 | β |
| Epigenetic mechanisms in the development and maintenance of dopaminergic neurons. | van Heesbeen HJ et al. | β | 2013 | β |
| From neural development to cognition: unexpected roles for chromatin. | Ronan JL et al. | β | 2013 | β |
| Generation of induced neurons via direct conversion in vivo. | Torper O et al. | β | 2013 | β |
| Generation of integration-free and region-specific neural progenitors from primate fibroblasts. | Lu J et al. | β | 2013 | β |
| Generation of integration-free neural progenitor cells from cells in human urine. | Wang L et al. | β | 2013 | β |
| Generation of oligodendroglial cells by direct lineage conversion. | Yang N et al. | β | 2013 | β |
| Glucose metabolism, hyperosmotic stress, and reprogramming of somatic cells. | Madonna R et al. | β | 2013 | β |
| Guest editorial: Opportunities in rehabilitation research. | Ommaya AK et al. | β | 2013 | β |
| Hacking cell differentiation: transcriptional rerouting in reprogramming, lineage infidelity and metaplasia. | Regalo G et al. | β | 2013 | β |
| How induced pluripotent stem cells are redefining personalized medicine. | Ferreira LM et al. | β | 2013 | β |
| Human L-ferritin deficiency is characterized by idiopathic generalized seizures and atypical restless leg syndrome. | Cozzi A et al. | β | 2013 | β |
| Identification of drug candidate against prostate cancer from the aspect of somatic cell reprogramming. | Kosaka T et al. | β | 2013 | β |
| Identification of transcription factors for lineage-specific ESC differentiation. | Yamamizu K et al. | β | 2013 | β |
| Implications and limitations of cellular reprogramming for psychiatric drug development. | Tobe BT et al. | β | 2013 | β |
| Induced neural stem cells generated from rat fibroblasts. | Xi G et al. | β | 2013 | β |
| Induced neural stem cells (iNSCs) in neurodegenerative diseases. | Hermann A et al. | β | 2013 | β |
| Induced pluripotency and direct reprogramming: a new window for treatment of neurodegenerative diseases. | Li R et al. | β | 2013 | β |
| Induced pluripotent stem cell (iPSC)-derived dopaminergic models of Parkinson's disease. | Beevers JE et al. | β | 2013 | β |
| Induced Pluripotent Stem Cells and Disorders of the Nervous System: Progress, Problems, and Prospects. | Faiz M et al. | β | 2013 | β |
| Induced pluripotent stem cells in medicine and biology. | Takahashi K et al. | β | 2013 | β |
| Induced pluripotent stem cell technology and direct conversion: new possibilities to study and treat Parkinson's disease. | Roessler R et al. | β | 2013 | β |
| Induced regeneration--the progress and promise of direct reprogramming for heart repair. | Addis RC et al. | β | 2013 | β |
| Induction of retinal ganglion-like cells from fibroblasts by adenoviral gene delivery. | Meng F et al. | β | 2013 | β |
| In vivo reprogramming of astrocytes to neuroblasts in the adult brain. | Niu W et al. | β | 2013 | β |
| Leveling Waddington: the emergence of direct programming and the loss of cell fate hierarchies. | Ladewig J et al. | β | 2013 | β |
| Leveling Waddington: the emergence of direct programming and the loss of cell fate hierarchies. | Ladewig J et al. | β | 2013 | β |
| Mesenchymal stem cells and neuroregeneration in Parkinson's disease. | Glavaski-Joksimovic A et al. | β | 2013 | β |
| Modeling Dravet syndrome using induced pluripotent stem cells (iPSCs) and directly converted neurons. | Jiao J et al. | β | 2013 | β |
| Modeling schizophrenia using induced pluripotent stem cell-derived and fibroblast-induced neurons. | Tran NN et al. | β | 2013 | β |
| Nanostructured superhydrophobic substrates trigger the development of 3D neuronal networks. | Limongi T et al. | β | 2013 | β |
| Neural regeneration. | Steward MM et al. | β | 2013 | β |
| Neural stem and progenitor cells in health and disease. | Ladran I et al. | β | 2013 | β |
| Neurons generated by direct conversion of fibroblasts reproduce synaptic phenotype caused by autism-associated neuroligin-3 mutation. | Chanda S et al. | β | 2013 | β |
| Notch inhibition induces cochlear hair cell regeneration and recovery of hearing after acoustic trauma. | Mizutari K et al. | β | 2013 | β |
| Optimization of direct fibroblast reprogramming to cardiomyocytes using calcium activity as a functional measure of success. | Addis RC et al. | β | 2013 | β |
| Physical cues of biomaterials guide stem cell differentiation fate. | Higuchi A et al. | β | 2013 | β |
| Plant science. Fine-tuning photosynthesis. | Rochaix JD | β | 2013 | β |
| [Possible applications of new stem cell sources in neurology]. | Hermann A et al. | β | 2013 | β |
| Progress and prospects in stem cell therapy. | Xu XL et al. | β | 2013 | β |
| Progress in the reprogramming of somatic cells. | Ma T et al. | β | 2013 | β |
| Proneural genes in neocortical development. | Wilkinson G et al. | β | 2013 | β |
| Prospects for replacement of auditory neurons by stem cells. | Shi F et al. | β | 2013 | β |
| Rapid generation of functional dopaminergic neurons from human induced pluripotent stem cells through a single-step procedure using cell lineage transcription factors. | Theka I et al. | β | 2013 | β |
| Rapid single-step induction of functional neurons from human pluripotent stem cells. | Zhang Y et al. | β | 2013 | β |
| Reciprocal modulation between microglia and astrocyte in reactive gliosis following the CNS injury. | Gao Z et al. | β | 2013 | β |
| Remodeling neurodegeneration: somatic cell reprogramming-based models of adult neurological disorders. | Qiang L et al. | β | 2013 | β |
| Reprogramming fibroblasts into bipotential hepatic stem cells by defined factors. | Yu B et al. | β | 2013 | β |
| Reprogramming fibroblasts to neural-precursor-like cells by structured overexpression of pallial patterning genes. | Raciti M et al. | β | 2013 | β |
| Reprogramming to pluripotency through a somatic stem cell intermediate. | Marthaler AG et al. | β | 2013 | β |
| Resetting epigenetic signatures to induce somatic cell reprogramming. | Lluis F et al. | β | 2013 | β |
| Reshaping the brain: direct lineage conversion in the nervous system. | Amamoto R et al. | β | 2013 | β |
| Revealing neuronal circuitry using stem cell-derived neurons. | Garcia I et al. | β | 2013 | β |
| "Seq-ing" insights into the epigenetics of neuronal gene regulation. | Telese F et al. | β | 2013 | β |
| Small molecules enable neurogenin 2 to efficiently convert human fibroblasts into cholinergic neurons. | Liu ML et al. | β | 2013 | β |
| Specification of dopaminergic subsets involves interplay of En1 and Pitx3. | Veenvliet JV et al. | β | 2013 | β |
| Standard recommendations for the application of Chinese clinical cell therapy for neurorestoration (2012). | Chinese Branch of International Association of Neurorestoratology (IANR) et al. | β | 2013 | β |
| Stem cells as promising therapeutic options for neurological disorders. | Yoo J et al. | β | 2013 | β |
| Switching cell fate, ncRNAs coming to play. | Guan D et al. | β | 2013 | β |
| [Target validation strategy in designing novel therapeutics for schizophrenia]. | Yoshimizu T et al. | β | 2013 | β |
| The argument from potentiality in the embryo protection debate: finally "depotentialized"? | Stier M et al. | β | 2013 | β |
| The BAF complex interacts with Pax6 in adult neural progenitors to establish a neurogenic cross-regulatory transcriptional network. | Ninkovic J et al. | β | 2013 | β |
| The role of single-cell analyses in understanding cell lineage commitment. | Gibson TM et al. | β | 2013 | β |
| Transcriptional regulation and specification of neural stem cells. | Christie KJ et al. | β | 2013 | β |
| Transcription factor-mediated reprogramming of fibroblasts to expandable, myelinogenic oligodendrocyte progenitor cells. | Najm FJ et al. | β | 2013 | β |
| A case of cellular alchemy: lineage reprogramming and its potential in regenerative medicine. | Asuelime GE et al. | β | 2012 | β |
| Accelerating progress in induced pluripotent stem cell research for neurological diseases. | Ito D et al. | β | 2012 | β |
| Activity-dependent regulation of the dopamine phenotype in substantia nigra neurons. | Aumann T et al. | β | 2012 | β |
| Amyloid precursor proteins, neural differentiation of pluripotent stem cells and its relevance to Alzheimer's disease. | Khandekar N et al. | β | 2012 | β |
| Animal models of Parkinson's disease 2012. | Imai Y et al. | β | 2012 | β |
| Application of reprogrammed patient cells to investigate the etiology of neurological and psychiatric disorders. | Christian KM et al. | β | 2012 | β |
| Association of Nurr1 gene mutations with Parkinson's disease in the Han population living in the Hubei province of China. | Lou X et al. | β | 2012 | β |
| Cardiac regenerative capacity and mechanisms. | Kikuchi K et al. | β | 2012 | β |
| Cellular programming and reprogramming: sculpting cell fate for the production of dopamine neurons for cell therapy. | Aguila JC et al. | β | 2012 | β |
| Cellular reprogramming: a new approach to modelling Parkinson's disease. | Hartfield EM et al. | β | 2012 | β |
| Cellular reprogramming: a small molecule perspective. | Nie B et al. | β | 2012 | β |
| Clinical application of stem cell therapy in Parkinson's disease. | Politis M et al. | β | 2012 | β |
| Converted neural cells: induced to a cure? | Zhang W et al. | β | 2012 | β |
| Cord blood-derived neuronal cells by ectopic expression of Sox2 and c-Myc. | Giorgetti A et al. | β | 2012 | β |
| Differentiation of chromaffin progenitor cells to dopaminergic neurons. | Vukicevic V et al. | β | 2012 | β |
| Direct conversion of dermal fibroblasts into neural progenitor cells by a novel cocktail of defined factors. | Tian C et al. | β | 2012 | β |
| Direct conversion of fibroblasts into stably expandable neural stem cells. | Thier M et al. | β | 2012 | β |
| Direct conversion of fibroblasts to functional neurons. | Yashar M et al. | β | 2012 | β |
| Direct lineage conversion: induced neuronal cells and induced neural stem cells. | Shi Z et al. | β | 2012 | β |
| Direct lineage reprogramming to neural cells. | Kim J et al. | β | 2012 | β |
| Direct reprogramming of fibroblasts into neural stem cells by defined factors. | Han DW et al. | β | 2012 | β |
| Direct reprogramming of human astrocytes into neural stem cells and neurons. | Corti S et al. | β | 2012 | β |
| Direct reprogramming of human fibroblasts into dopaminergic neuron-like cells. | Liu X et al. | β | 2012 | β |
| Direct reprogramming of mouse and human fibroblasts into multipotent neural stem cells with a single factor. | Ring KL et al. | β | 2012 | β |
| Dopaminergic neurons from midbrain-specified human embryonic stem cell-derived neural stem cells engrafted in a monkey model of Parkinson's disease. | Daadi MM et al. | β | 2012 | β |
| Effect of low-dose thalidomide on dopaminergic neuronal differentiation of human neural progenitor cells: a combined study of metabolomics and morphological analysis. | Qin XY et al. | β | 2012 | β |
| Egr-1 induces DARPP-32 expression in striatal medium spiny neurons via a conserved intragenic element. | Keilani S et al. | β | 2012 | β |
| Experimental and therapeutic opportunities for stem cells in multiple sclerosis. | Patani R et al. | β | 2012 | β |
| Generation of motor neurons from pluripotent stem cells. | Chipman PH et al. | β | 2012 | β |
| Genetic strategies to investigate neuronal circuit properties using stem cell-derived neurons. | Garcia I et al. | β | 2012 | β |
| Heart repair by reprogramming non-myocytes with cardiac transcription factors. | Song K et al. | β | 2012 | β |
| 'Hearts and bones': the ups and downs of 'plasticity' in stem cell biology. | Bonfanti P et al. | β | 2012 | β |
| Human-induced pluripotent stem cells: in quest of clinical applications. | Madonna R | β | 2012 | β |
| Human pluripotent stem cells for disease modelling and drug screening. | Maury Y et al. | β | 2012 | β |
| Induction of fibroblasts to neurons through adenoviral gene delivery. | Meng F et al. | β | 2012 | β |
| Induction of neural differentiation by the transcription factor neuroD2. | Messmer K et al. | β | 2012 | β |
| Intestinal dysmotility and enteric neurochemical changes in a Parkinson's disease rat model. | Colucci M et al. | β | 2012 | β |
| Lineage conversion methodologies meet the reprogramming toolbox. | Sancho-Martinez I et al. | β | 2012 | β |
| Maintaining differentiated cellular identity. | Holmberg J et al. | β | 2012 | β |
| microRNA induced transdifferentiation. | Shenoy A et al. | β | 2012 | β |
| Microtubule destabilization is shared by genetic and idiopathic Parkinson's disease patient fibroblasts. | Cartelli D et al. | β | 2012 | β |
| Modeling psychiatric disorders through reprogramming. | Brennand KJ et al. | β | 2012 | β |
| Molecular mechanisms of induced pluripotency. | Muchkaeva IA et al. | β | 2012 | β |
| Molecular roadblocks for cellular reprogramming. | Vierbuchen T et al. | β | 2012 | β |
| Neural stem cell transplantation in central nervous system disorders: from cell replacement to neuroprotection. | De Feo D et al. | β | 2012 | β |
| Nonviral direct conversion of primary mouse embryonic fibroblasts to neuronal cells. | Adler AF et al. | β | 2012 | β |
| Non-Viral Generation of Neural Precursor-like Cells from Adult Human Fibroblasts. | Maucksch C et al. | β | 2012 | β |
| Parkinson's Disease in a Dish: What Patient Specific-Reprogrammed Somatic Cells Can Tell Us about Parkinson's Disease, If Anything? | Drouin-Ouellet J et al. | β | 2012 | β |
| Polyglutamine (polyQ) disorders: the chromatin connection. | Cohen-Carmon D et al. | β | 2012 | β |
| Producing striatal phenotypes for transplantation in Huntington's disease. | Precious SV et al. | β | 2012 | β |
| Programming and reprogramming neuronal subtypes in the central nervous system. | Rouaux C et al. | β | 2012 | β |
| Progress on stem cell research towards the treatment of Parkinson's disease. | Gibson SA et al. | β | 2012 | β |
| Reprogramming cell fates: insights from combinatorial approaches. | Pereira CF et al. | β | 2012 | β |
| Reprogramming of pericyte-derived cells of the adult human brain into induced neuronal cells. | Karow M et al. | β | 2012 | β |
| Restoration of the striatal circuitry: from developmental aspects toward clinical applications. | Pauly MC et al. | β | 2012 | β |
| Significance of F3/Contactin gene expression in cerebral cortex and nigrostriatal development. | Massaro A et al. | β | 2012 | β |
| Small molecules, big roles -- the chemical manipulation of stem cell fate and somatic cell reprogramming. | Zhang Y et al. | β | 2012 | β |
| Specification of functional neurons and glia from human pluripotent stem cells. | Jiang Y et al. | β | 2012 | β |
| Stem cells and regenerative therapies for Parkinson's disease. | Farrell K et al. | β | 2012 | β |
| Stem cells as in vitro model of Parkinson's disease. | MartΓnez-Morales PL et al. | β | 2012 | β |
| Stem cell therapy for cerebral ischemia: from basic science to clinical applications. | Abe K et al. | β | 2012 | β |
| The function and mechanisms of Nurr1 action in midbrain dopaminergic neurons, from development and maintenance to survival. | Luo Y | β | 2012 | β |
| The immunological challenges of cell transplantation for the treatment of Parkinson's disease. | Piquet AL et al. | β | 2012 | β |
| The many roads to Rome: induction of neural precursor cells from fibroblasts. | Lujan E et al. | β | 2012 | β |
| The path from skin to brain: generation of functional neurons from fibroblasts. | Abdullah AI et al. | β | 2012 | β |
| The potential of induced pluripotent stem cells as a translational model for neurotoxicological risk. | Kumar KK et al. | β | 2012 | β |
| Therapeutic application of neural stem cells and adult neurogenesis for neurodegenerative disorders: regeneration and beyond. | Latchney SE et al. | β | 2012 | β |
| Time to reconsider stem cell induction strategies. | Denker HW | β | 2012 | β |
| Tracing synaptic connectivity onto embryonic stem cell-derived neurons. | Garcia I et al. | β | 2012 | β |
| Transcriptional code and disease map for adult retinal cell types. | Siegert S et al. | β | 2012 | β |
| Transcription factor-mediated epigenetic reprogramming. | Sindhu C et al. | β | 2012 | β |
| Understanding cancer stem cell heterogeneity and plasticity. | Tang DG | β | 2012 | β |
| What do we know about the neurogenic potential of different stem cell types? | Lepski G | β | 2012 | β |
| Cell therapeutics in Parkinson's disease. | Lindvall O et al. | β | 2011 | β |
| Cellular reprogramming: recent advances in modeling neurological diseases. | Ming GL et al. | β | 2011 | β |
| Concise review: alchemy of biology: generating desired cell types from abundant and accessible cells. | Pournasr B et al. | β | 2011 | β |
| Converting human skin cells to neurons: a new tool to study and treat brain disorders? | Kim KS | β | 2011 | β |
| Direct conversion of human fibroblasts to functional neurons in one step. | Berry N et al. | β | 2011 | β |
| Direct lineage conversion of terminally differentiated hepatocytes to functional neurons. | Marro S et al. | β | 2011 | β |
| Direct lineage conversions: unnatural but useful? | Vierbuchen T et al. | β | 2011 | β |
| Direct reprogramming of adult human fibroblasts to functional neurons under defined conditions. | Ambasudhan R et al. | β | 2011 | β |
| Efficient conversion of astrocytes to functional midbrain dopaminergic neurons using a single polycistronic vector. | Addis RC et al. | β | 2011 | β |
| Electrophysiological properties of embryonic stem cell-derived neurons. | Risner-Janiczek JR et al. | β | 2011 | β |
| Functional integration of dopaminergic neurons directly converted from mouse fibroblasts. | Kim J et al. | β | 2011 | β |
| Gene expression profiling of embryonic human neural stem cells and dopaminergic neurons from adult human substantia nigra. | Marei HE et al. | β | 2011 | β |
| Induced neuronal cells: how to make and define a neuron. | Yang N et al. | β | 2011 | β |
| Induced pluripotent stem cells (iPSCs) and neurological disease modeling: progress and promises. | Marchetto MC et al. | β | 2011 | β |
| Notable advances 2011. | Basson M et al. | β | 2011 | β |
| Novel paths towards neural cellular products for neurological disorders. | Daadi MM | β | 2011 | β |
| Pluripotent stem cells for the study of CNS development. | Petros TJ et al. | β | 2011 | β |
| Regenerative medicine: Bespoke cells for the human brain. | Sendtner M | β | 2011 | β |
| Reprogrammed Astrocytes as a Potential Therapy for Neurodegenerative Disorders. | Tian C et al. | β | 2011 | β |
| Setting a highway for converting skin into neurons. | Broccoli V et al. | β | 2011 | β |
| The labyrinth of nuclear reprogramming. | Sancho-Martinez I et al. | β | 2011 | β |
| Turning skin into dopamine neurons. | Parmar M et al. | β | 2011 | β |